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Abstract 
 
Pediatric asthma is a serious illness that poses tremendous stress on patients and 
their families alike.  Unfortunately the disease's incidence is on a rise 
worldwide. 
 Pediatric asthma is a chronic disease affecting the small bronchi leading to 
inflammation with subsequent edema and hypersecretion resulting in narrowing 
of the lumen demonstrated in cough, dyspnea and wheezes. Pollution, cigarette 
smoke, dust mite, domestic animal and extreme weather conditions are 
considered causative and triggering factors. Genetic factors play critical role in 
respiratory hypersensitivity also identified to be an important risk factor in  
pediatric asthma. 
Children are primary victims, being exposed, early on in life, to thousands of 
attacks of acute severe asthma  and  requiring hospital referral.  The study aims 
was to identify the most prevalent  environmental - genetic risk factors that 
affect pediatric asthma in east Jerusalem/ Palestine. 
 
The sample size consists of 300 children from East Jerusalem between 5 and 16 
years old.  One hundred patients represent bronchial asthma ,case and 200 with 
other diseases. 
 
The purposive sample is taken from four medical centers in East Jerusalem and 
two major medical institution ,Al- Makassed Islamic Charitable Hospital and 
Augusta Victoria Hospital (AVH). The study was approved by the scientific 
research committee at Al –Quds University, and a permission to conduct the 
study from the administration of  Al- Makassed Islamic Charitable center, the 
Arab medical health center, the American medical center and from the 
Palestinian ministry of health center also along with permission from AVH and 
Makassed Islamic Charitable Hospital was obtained   
 
The Alpha 1 Antitrypsin genotype was perform for 50% of the samples (50 
case, 100 control) in addition 300 questionnaire was distributed for 300 families 
of children selected in the study area . Pearson chi square was used to check the 
association of   environmental risk factors that affect pediatric asthma in east 
Jerusalem Palestine. Result of the study demonstrate that there is a strong 
association between  pediatric asthma and the presence of domestic animal in 
home , second hand smoking, and family history of asthma is strongly related to 
asthma .on the other hand genetic risk factor  is poorly associated  with asthma 
among children in east Jerusalem /Palestine. 
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 ملخص الدراسة
داء الربو القصبي مرض مزعج يقض مضاجع المصابين بو والذين يعيشون معيم وىو 
فالربو ىو مرض مزمن يصيب الرئة ويؤدي إلى . آخذ في الانتشار سنة تمو الأخرى
ويعتبر . التياب الشعب اليوائية الصغيرة مما يتسبب في السعال وضيق التنفس والأزيز
 والحيوانات الببيتية وطبيعة الطقس من العوامل  التمّوث والتدخين والغبار والعث المنزلي
.  التي تسبب الربو ، بالإضافة أن المرضى المصابين بالربو لدييم استعداد وراثي 
والأطفال ىم ضحاياه الأوائل ويتعرض الآلاف منيم، وأكثرىم في عمر مبكر، لأزمات ربو 
ىدفت ىذه الدراسة إلى التعرف عمى العوامل البيئية . لا يمكن تيدئتيا إلا في المستشفيات
/ والجينات الوراثية المحفزة و المساعدة في تأزم نوبة الربو في منطقة شرقي القدس 
 -1- ahplA(  :فمسطين، وخصص من ىذه الجينات نقص نوع من البروتينات ألا وىو
 ) amhtsa cirtaidep  gnoma ycneicifed nispyrtitnA
، حيث ) من أمراض أخرى002-  مصاب بالربو001( طفل، 003اشتممت العّينة عمى 
 رئوية وقد كانت العّينة بالتيابات)noitcefni tsehC(    تم استثناء الأطفال المصابين 
 سنة، ىذا وقد 61 – 5مستيدفة من كل أطفال شرقي القدس الذين تتراوح أعمارىم ما بين 
تم أخذ العّينة من المراكز الصحّية المّوزعة في شرقي القدس بالإضافة إلى مستشفى 
وقد تمت الموافقة عمى ىذه الدراسة من قبل لجنة البحث . المقاصد ومستشفى المّطمع
العممي في جامعة القدس كما وأخذت موافقة مدراء المراكز التي تمت فييا الدراسة 
،  الصحي العربيزالمرك، مركز الأمريكان، واشتممت عمى مراكز جمعيو المقاصد الخيرية
تم فحص . السمطة الوطنية ومستشفى المقاصد ومستشفى المّطمع/ مركز صحة القدس
في حدوث نوبة الربو المساعدة من العينة المستيدفة لمبحث عن الجينات الوراثية % 05
تم اختبار العينة عن طريق .  استبيان عمى جميع العينة في منطقة القدس003كما ووزع 
 وقد أشارت الدراسة  وجود علاقة إحصائية  بين داء erauqs ihc nosraePاستعمال 
ووجد أيضا علاقة قوية مع الحيوانات ، الربو القصبي والتدخين في بيئة الطفل المصاب
من ناحية أخرى لم يثبت وجود .  يمعب دور ىاماٌعاًِ اٌٛساثٟ المنزلية بلاضافة إلى أن 
.  وداء الربو  ycneicifed nispyrtitnA -1- ahplA((علاقة بين الجينات الوراثية 
 المصابين بمرض الربو نإننا نوصي بدراسات أخرى بحيث تكون شاممة عمى عدد أكثر م
. ومساحة اكبر
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Chapter one 
1. Introduction 
1.1General background 
Pediatric asthma is a chronic respiratory condition that affects the lung of a 
child and is characterized by narrowing of air channel and inflammation of 
bronchial wall and muscles, which result in extra mucus production (Mayo 
clinic, 2004)  The mucus will accumulate and result in symptom of wheezing 
cough and  tightening of chest (James, Robert 1999 ) ''Asthma is most simply 
defined as a disorder characterized  by narrowing of  airways that is reversible 
with time , either spontaneously or as a result of treatment " (Fores and Jacson, 
2003). 
Asthma is classified into three stage: Acute, subacute and chronic. These stages  
will explain the pathophysiology of asthma as a complex disease which result in 
airway inflammation or intermittent airflow abstraction and bronchial 
Hyperresponsiveness (Morris, etal 2005) In 2002, it was show  that the 
incidence, prevalence and mortality of Asthma have increased in children over 
the past three to four decades (Smyth .R, 2002). 
 
1.2 Asthma occurrence and severity 
 Many factors play a role in asthma occurrence and severity including 
environmental , genetic and hygiene factors in addition to lifestyle differences 
which  play potentially causative roles in USA   (Smyth, 2002). The main 
causes of asthma are unknown but may be related to environmental factors such 
as indoor and outdoor pollution (Anderson, 1994). In 1999 approximately 25 
children and more than 500 adult younger than 65 years died from asthma" 
(Smyth, 2002). These trends provide some reassurance that the increase in 
hospital admissions in children that has occurred over the past three decades has 
not been associated with as increase in the life threatening events in this age 
group (Smyth, 2002). Both inherent and environmental factors influence  the 
development of  asthma in childhood ; Sex ,genetic predisposition  and lung size 
are regarded as inherent factors ,while  diet, allergen, environmental pollution 
including  tobacco smoke, infection, socioeconomic status and region of 
residence are considered  external factors (Barnes,1998)  
A major obstacle in the genetics  studies of asthma  is the  clinical diagnosis 
because no  single clinical parameter always delineates asthma from other 
pulmonary diseases or a healthy state ( Barnes,1998). Certain well-defined 
genotypes such as S ,Z exits that are strongly associated with Asthma, also 
mutation in different genes may result in identical Genotypes; genetic 
heterogeneity. (Barnes, 1998) 
alpha-1 Antitrypsin (AAT) deficiency have been interpreted as indicating that 
AAT deficiency is a rare disease that affects mainly Caucasians (whites) from 
northern Europe. (Frederick, 2003) 
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  In a recent publication on worldwide racial and ethnic distribution of AAT 
deficiency, new data were presented demonstrating that it is also found in 
various populations including  African blacks ; Arabs and Jews in the Middle 
East ; and Central, Far East, and Southeast Asians, as well as among  whites in 
Australia, Europe, New Zealand, and North America (Frederick,2003)The new 
data on the incidence of AAT deficiency worldwide and the suggestion that it 
may be the most common single gene hereditary disease for humans mandate 
the development of better mechanisms for effective diagnosis and treatment. 
Alpha-1 Antitrypsin deficiency is an inherited disorder that can cause lung and 
liver disease in children. Alpha-1 Antitrypsin (AAT) is a protein that protects 
the lungs. The liver usually makes the protein, and releases it into the 
bloodstream. Because of a gene problem, some people have little or none of it 
(Frederick, 2003). 
The large numbers of AAT deficiency carriers and those with deficiency allele 
combinations for the two most common alleles PiS and PiZ worldwide clearly 
indicate that most carriers and deficiency allele combinations for PiS and PiZ 
have not been diagnosed (Geogr,1994) The fact that this disease is not just a 
disease of white northern Europeans but affects essentially all racial subgroups 
worldwide impacts the commonly accepted standards for diagnosis of AAT 
deficiency by general practitioners and such specialists as allergists and 
pulmonary and hepatic physicians. Particularly important is the unique 
sensitivity of AAT-deficient individuals to exposure to chemical and particulate 
environmental agents. (Frederick, 2003). 
1.3 Risk factors for asthma  
Many factors appear to play a role in both the etiology of asthma and its 
exacerbation. It is not clear which factors are causative and which are promoters 
of the disease. Risk factors are determinants of the risk of developing childhood 
asthma and may increase or decrease the probability of an individual, and can be 
personal characteristics - inherited or acquired or environmental characteristics 
(Badash, 2001) 
 Asthma can develop at any age and has to be considered in every child 
presenting with wheezing although some studies suggest racial differences in 
the prevalence of asthma. Socio-economic and environmental differences must 
be taken into account when conclusions are made in this regard(Andrew 
,etal,2000)   Inhalation of cigarette smoke during pregnancy have linked with 
abnormal lung functions, airway hyper-reactivity and raised IgE levels in the 
newborn. (Kathleen, etal, 2003) Tobacco smoke is also an important trigger 
factor for asthma attacks (Kathleen,etal,2003)  Viral infections are important 
triggers for asthma attacks .(Sigurs N,2000)  There is no conclusive evidence to 
indicate that early infancy viral infection lower respiratory tract illnesses lead to 
subsequent long term increase in airway responsiveness and asthma. Viral 
infections are a major cause of wheezing in early infancy, but proof of induction 
of the asthma state with typical airway inflammation as found in the known 
asthmatic is still lacking. (Sigurs N, 2000) 
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A complex relationship exists between atopy and asthma. Umbilical cord blood 
IgE is a poor predictor of early infant wheezing, but if children with a raised 
cord blood IgE of >0,9 KU/l are followed to the age of 11 years, a five fold 
increase risk for asthma is found.(Johnson.etal,2002) 
Many different foods and preservatives have been implicated in triggering 
asthma attacks. (Smit, 2001)  Inducing the asthma state by certain food 
substances have not been proven. Food elimination diets have been shown to 
postpone the development of atopic eczema, urticaria and gastrointestinal tract 
allergic disease but not asthma (Smit, 2001)  
There is increasing evidence that early exposure to inhaled allergens (house dust 
mites, moulds, cats, "cockroach, pollen") in the genetically predisposed infant 
may lead to increased airway responsiveness and asthma. The increase of the 
prevalence of atopy when born in a specific month of the year can also be 
attributed to early exposure to the prevailing allergen at that specific time 
(Richard, 2005) 
Emotional factors play a major role in eliciting asthma attacks in the known 
asthmatic. (Weil.m,1999)  No evidence exists that asthma can be induced by 
these factors. Certain psychological factors are seen as risk factors for eliciting 
severe and fatal asthma attacks .also behavioral and psychosocial factors affect 
asthma morbidity
 
in children(Weil.m,1999) Patients with asthma who are at risk 
from an allergy trigger need to be identified. Other triggers include respiratory 
tract infections, certain drugs, and both indoor and outdoor 
pollutants.(Etzel,2003) 
1.4 problem statement and study justification 
 
Bronchial Asthma is a common chronic respiratory disease among children. 
Shortness of breath, wheezing, coughing are known to be the major symptoms.  
there are many provoking factors that lead to spasm or constriction of airways 
such  as: cold air, construction dust, strong fumes, smoke, Inhaled irritants and 
emotional upset.  In addition, children with genetic risk factors have a high risk 
for bronchial asthma.( Smyth , 2002) 
Bronchial Asthma is a common disease among children worldwide and in 
Palestine as well .Nationally many studies were done about asthma, discussing: 
Pathophysiology of asthma (AAAAI,2006), structure of lung tissue during 
asthma attack(American Lung Association,2007) , environmental and genetic 
risk factors for asthma  (NIEHS,2006) , morbidity and mortality of asthma 
(American Lung Association, 2005), biological risk factors are discussed in 
American journal  of respiratory care . (Stefania, etal, 2003)   In Palestine 
bronchial asthma is one of a common disease in childhood. (Palestinian Central 
Bureau of Statistics ,2000)  Few studies were done,   investigate the prevalence 
and severity of asthma. (El Sharif N, etal, 2002). 
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Other  researcher looked for domestic mite and pet allergens and endotoxin in 
Ramallah / Palestine, Geographical variations of asthma and asthma symptoms 
among schoolchildren were studied among  familial diseases as  significant 
predictors of childhood asthma in Ramallah and North Gaza in Palestine. (El 
Sharif N, etal, 2003)  Moreover, indoor environment such as presence of cats 
and domestic moulds also appear to play a role. (El Sharif N, etal, 2003) 
.Attendance of asthma in emergency room was considered (Mohammad ,2006). 
And  no previous study was held to discuss the role of environmental -genetic 
risk factors in pediatric asthma .  
In this study we will try  to identify the most environmental  risk factors that 
contribute to the development of  pediatric asthma in east Jerusalem. Our large 
interest is applied to detect the role of alpha- 1- Antitrypsin (Proteinase inhibitor 
PI) in serum and the most common mutation subtypes( PIZ -PIS )as a genetic 
disorder that increases asthma severity and occurrence. The different genotypes 
studies  could give a clear idea  about pathogenesis of asthma in east Jerusalem. 
Association between environmental –genetic risk factor in pediatric asthma  
could  add new information about the role AAT deficiency in pediatric asthma 
severity in east Jerusalem Palestine and suggest new intervention. 
 
1.5 Goal of the study 
To identify the most environmental - genetic risk factors that affect pediatric 
asthma in east Jerusalem/ Palestine.    
 
1.6 Objectives of the study  
 
 1.6.1 General objectives 
 
1.     A clear idea about asthma pathogenesis in east Jerusalem/ Palestine. 
2.     Assess the potential risk factors for childhood asthma                                                                                                                                                                                                           
3.    Recognize some common indoor environmental factors that plays a role in   
increasing asthma prevalence.  
4.  Investigate the role of alpha -1- Antitrypsin genotype  in child hood                                                                          
asthma. 
5.     Evaluate the parent's knowledge about Asthma management. 
 
1.6.2 Specific objectives: 
 
1.      To determine the relation between the  presence of indoor Environmental                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
risk factor and  pediatric asthma.                                    
   
 2.   To assess the relation between socio-demographic variables (including                                                                                                                            
parents knowledge, etc) and frequency of pediatric asthma attack.           
   
3.  To determine the most common subtypes of PIM mutation that                      
contributes to genetic asthma in childhood    in east Jerusalem/ Palestine 
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4. To estimate the frequency of carriers and the number of those individuals    
who are homozygous and heterozygous for the Z, S defective alleles    of AAT 
deficiency 
 
                                
1.7 Research questions 
 
The investigation was initiated to answer the following questions 
1. What is the most environmental risk factor for pediatric asthma  in east 
Jerusalem/ Palestine  
 
2.  What is the percentage of Alpha -1- Antitrypsin deficiency among 50 
case=50% of total number of asthmatic child? 
 
3.  What is the percentage of Alpha -1- Antitrypsin deficiency among 100 
control=50% from anther diseases except upper and lower respiratory tract 
infection? 
    
 
1.8 Study hypotheses 
 
1.   Alpha -1- Antitrypsin deficiency is correlated with the severity of asthma. 
2.   The genetic factor increases the frequency of asthma.  
3.   Children with family history of asthma are more susceptible to respiratory                             
problem upon expose to environmental risk factor.   
4.   Environmental genetic interaction plays a role in the prevalence of asthma   
   
1.9 Thesis chapter's description  
 
This thesis consists of six chapters: 
 
Chapter 1:  give a view about background, significance, Asthma occurrence and 
severity, Problem statement and study justification, aim and objectives of the 
study, hypotheses and question. Further more, we described the demography of 
east Jerusalem area, and we focused on the villages around. 
 
                        
Chapter 2:    Review for literature and previous studies, about asthma and 
genetic factors, especially alpha one Antitrypsin deficiency and focus on 
Pathophysiology and the risk factors of Pediatrics Asthma also mention Genetic 
transmission of AAT deficiency. 
                                                                                                                                                                                                                       
Chapter 3: Conceptual frame work, including asthma definition, its natural 
history, path physiology of alpha1 Antitrypsin deficiency, Epidemiology of 
Alpha one Antitrypsin   , and Intervention studies. 
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 Chapter 4: Describes the methodology followed, including study design, sample 
size, population, data collection and analysis, Sampling Approaches,    Ethical 
Consideration, and Pilot testing. 
 
Chapter 5: Presents the main results and finding. 
 
Chapter 6: Discuses the main study results including socio-demographic, 
environmental and genetic risk factor effect. The study results with previous 
studies are discussed. At the end of the chapter, the main conclusions, 
recommendations,  and suggestion. 
Chapter 7: References 
 
1.10 Demography of east Jerusalem 
Jerusalem occupies a unique status in the life of Palestinians, not only because 
of its religious importance, but also because of the historic role the city has 
played in Palestinian economic, social and cultural life. Regarded as the most 
important Palestinian city, Jerusalem is held up as the future capital of an 
independent Palestinian state (Mustapha, 2000) 
 The current total population of the Jerusalem Governorate is (470103) residents 
with a distribution of 246651in J1 area and 223452 in J2 area (PCBS, 2003). 
The Health status of East Jerusalem population is generally good with health 
indicators resembling those of a middle-income country. Indicators of health 
status such as life expectancy are among the best in the region. Men have an 
average life expectancy of 69, while women are at 71. Infant mortality, another 
important indicator, is low, at 17/1000 as compared to the West Bank, Israel and 
other countries (PCBS, 2000) 
1.10.1 Health care providers: 
 The Palestinian Ministry of Health has a big role as health care providers in 
east Jerusalem Governorate. Its activities are focus in the area outside the 
Jerusalem Municipality boundaries and provide PHC services to the Palestinians 
based on the Palestinian Governmental Health insurance. (PCBS, 2000). 
The MOH runs 16 PHC clinics distributed in the villages around Jerusalem, the 
main Health center in Ezaria, which operates 6 days a week, as seen in 
(Appendix 1.1) 
Makassed Charitable Society operates five health centers in Jerusalem area; two 
inside the municipal boundaries and three in the suburbs. The largest centers are 
located in the Old City and al-Ram. These clinics offer a variety of services that 
includes: general medicine, specialized clinics, and x-ray and laboratory basic 
facilities (Khamaisy, 1997), as seen in( Appendix 1.2) The remaining health 
care providers can seen in( Appendix 1.3 , 1.4 , 1.5,  1.6 ) 
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 1.10.2 East Jerusalem governorates: 
The administrative classification of the ministry of local Government that were 
used in the 1997 census , divided the Palestinian Territory into nine 
governorates one of them was Jerusalem governorate which  includes 30 
different zones   (see the map Appendices 4.8) 
These are AL-Ezaria(Bethany), Abu-Dees, AL-Sawahreh ash sharqiya, Asheikh 
Sa'd,Arab Al Jahlen, Anata, Qalandia, Qatanna, Al-Jeeb, Al-Qubieba, Al-Nabi 
Smawil, Al-Ram ٚ Dahiyat al Bareed, Beit Ijza, Biddu, Beit Iksa, Beit surrik, 
Biet Duqqu, Biet Hanina Al-Balad, Biet Anan , Bir Nabala , Jaba, Hizma, 
Kharayib um al-lahim, Rafat, Kafar Aqab, Mikhmas,and Qalandia camp. 
The population housing density in the Jerusalem Governorate is 1.79 and about 
19.9% of all household live in housing units with three persons or more per 
room (PCBs, housing report, 2000). 
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Chapter 2. Literature review 
 
2.1. Introduction 
 
Asthma is a clinical syndrome characterized by airway Hyperresponsiveness 
and airway inflammation. Furthermore; pediatric asthma is considered one of 
the most common chronic diseases of childhood that causes inflammation and 
spasm or tightening in the bronchial tubes which are responsible of carrying air 
to the lung. (Hughes, 2004). Its clinical manifestation is not as typical as adult 
asthma. Recurrent episodes of cough and wheezing are the most frequent 
symptoms. However, numerous investigations of the occurrence of pediatric 
asthma have been conducted worldwide. In the United States, data from 
nationwide samples and survey populations indicate that asthma is a common 
disease in children, with an overall prevalence of 5% (James, 1999). 
Asthma can start at any age, but the majority of all people with asthma had their 
first symptoms by the age of 10. On the other hand, a big proportion of children 
with asthma had their first asthma attack before the age of six. (Morres,2005). 
The exact causes of asthma are not fully understood, and the disease is probably 
caused by interaction of hereditary and environmental factors, but how they 
interact together is still not fully investigated. However, many endogenous and 
exogenous risk factors have been identified for asthma.  Studies of familial 
aggregation of asthma and twins show a strong familial influence on the 
prevalence of asthma without separation between genetics from common 
environmental effects. However, all individuals with asthma have a 
characteristic hyper reactivity of the airways to a variety of   environmental 
factors, including irritants such as house dust mites and pollutants; strong odors; 
cold air; and rapid changes in temperature and humidity.  Descriptive studies of 
pediatric asthma have consistently shown an increased prevalence in males, 
which may be explained by differences in airway geometry. (Masoli ,etal 
,2004). Atopy, defined by positive skin tests to common aeroallergens, predicts 
increased risk of asthma if present in parents or child. Moreover, episodes of 
lower respiratory tract infection are associated with subsequent asthma and 
increased airway reactivity (Payne, etal 2004). Ambient air pollution may 
exacerbate asthma, but it has not been established as a risk factor for childhood 
asthma. Similarly, environmental tobacco smoke has been shown to exacerbate 
asthma, but its role in the development of asthma is uncertain. (Marittas, 2002) 
.  
On the other hand; Alpha 1 – Antitrypsin deficiency is a hereditary autosomal 
disorder, resulting from a variety of mutations in alpha one Antitrypsin gene and 
associated with a high risk for the development of early onset of pulmonary 
emphysema. (Stockley, 2001).Also alpha one Antitrypsin deficiency phenotypes 
have been noted to contribute to highlight the risk of developing asthma and a 
topic diseases especially in children. (Wenzel, 2004). ). However; many studies 
have proved an association between alpha one Antitrypsin deficiency and 
asthma. For example, information from the British Registry of alpha one 
Antitrypsin deficiency patients has reported the occurrence of asthma in 11% of 
the cases. (Luisetti, 2004). 
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 In addition to that other researchers such as Seersholm and his colleagues found 
an increase in the prevalence of MS phenotype to 18% and MZ phenotype to 
7% among Puerto Rican children  attending the asthma clinic in New York city 
in the United States (Seersholm, etal, 2000) 
On the other hand; Edward Eden from Columbia University reported  that 
genetic testing of asthmatic people to investigate the deficiency of alpha one 
Antitrypsin phenotypes is very important as abnormal phenotypes are associated 
with an increased prevalence and severity of asthma, (Edward, 1997). Other 
researchers suggested that normally alpha one antitrypsin modulates the effect 
of inflammatory mediators involved in the pathogenesis of asthma. (Luisetti, 
2004).  Furthermore; the development of asthma in patients with deficiency 
phenotypes of alpha one antitrypsin will increase the rate of the development of 
irreversible airway obstruction and emphysema in a mechanism that asthma and 
alpha one antitrypsin deficiency are connected path physiologically. 
(Schluchter, etal. 2000)  The present study is the first case –control study in 
Palestine to estimate the number of carriers and the number of those individuals 
who are homozygous or heterozygous for the Z, S defective alleles of AAT 
deficiency among 150 children in east Jerusalem .also environmental risk factor 
such as family history of asthma, domestic animal and second hand smoking 
and different Sociodemographic variables will be included. 
2.2 Normal Lungs Function 
Air usually enters the nose and mouth and goes down the air tube (trachea) to 
two main air passages (bronchi). These passages allow air to go into the right 
and left lung.   Each bronchus branches out into grape-like air sacs called 
alveoli. Through the alveoli, oxygen enters the bloodstream during breathing in 
(inspiration), and carbon dioxide, a waste product, leaves the body during 
breathing out (expiration).as seen in Figure 2.1 
Figure 2.1:  normal lungs 
 
Source: - MedicineNet.com 
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Figure 2.2:  lungs during asthma attack 
 
 
(Source : Mister seed's Health Centre, 1994). 
Figure 2.3 Normal Asthmatic Bronchiole 
During asthma attack smooth muscles located in the bronchioles of the lung 
constrict and decrease the flow of air in the airways. The amount of air flow can 
further be decreased by inflammation or excess mucus secretion. (Frederic, 
2004). 
(Source: Department of Allergy and Pulmonary/Critical Care Medicine, Boston 
University, 2004.) 
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 2.3. Pathophysiology and contributing factors of Pediatrics Asthma 
 
The exact cause of asthma is not yet understood, but through an asthma attack, 
the airways in the lungs react to some stimulus or trigger. In response to 
exposure to these triggers, the bronchi contract into spasm. Inflammation soon 
after follows, leading to a further narrowing of the air ways and increased 
mucus production which leads to wheezing, coughing and other breathing 
problems. (Lilly, 2006). In severe causes of asthma, damage to the lungs can 
accumulate over time, resulting in permanent narrowing of the airways.  
However; two factors contribute in provoking asthma; these are either triggers 
or inducers. Triggers irritate the airways and result in bronco constriction, and  
children with asthma when they encounter a trigger, an exacerbation can occur. 
Triggers are common, including, cold air; dust, strong fumes; exercise; 
emotional upsets; smoke; and inhaled irritants. On the other hand, inducers 
cause both airway inflammation and are defined to be causes of asthma. The 
most common known inducers are allergens and respiratory viral infections. 
(Brunekreef, 2002). 
Prevalence and severity of childhood asthma were studied in 200 asthmatic 
children Remission of asthma was defined as a period of at least 2 years free of 
asthma while receiving no treatment. In their study univariate analysis showed 
significant associations between persistence of asthma and perennial symptoms 
with an odds ratio (OR) of 2.5 ; sensitization to house dust mites OR 3.5 ; 
sensitization to molds, OR 7.9 ; sensitization to pollen, OR 4.8; and 
sensitization to milk protein, OR 5.4. Researchers found that there was a 
positive association of remission of asthma with good treatment compliance, 
OR 12.1. (Anderson, etal .1994) 
In 2001 cross-sectional national
 
survey was done  in Taiwan , 35 036 age 
selected from  6- to 15-year-old schoolchildren from 22 elementary and 22 
middle schools located within 1-km
 
in area of Taiwan  Parental atopy and 
environmental exposures are recognized
 
risk factors for childhood asthma. This 
study was undertaken
 
to identify risk factors, estimate the population 
attributable
 
risk of each exposure, and compare the data for boys versus
 
girls for 
physician-diagnosed asthma in Taiwanese school children.
 
 Investigation 
hereditary and indoor and outdoor
 
environmental factors for childhood asthma 
by questionnaire.
 
Parental atopy contributed more to childhood
 
asthma than did 
indoor or outdoor environmental factors. Exposure
 
to indoor/outdoor 
environmental factors increased the risk of
 
asthma in children regardless of the 
coexisting hereditary factors. (Ling, Y, 2003) 
In general either triggers or inducers, the contributing factors in pediatric asthma 
can be summarized as follows: 
 
2.3.1. Bronchial hyper reactivity 
 
Bronchial hyper reactivity means that the intra thoracic airways of the asthmatic 
child narrow to a far greater degree in response to certain stimuli. The 
mechanisms of airway hyper responsiveness are numerous and complex.  
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The inflammatory process is very important, It is characterized by epithelial 
damage and sloughing, by cellular infiltration of the bronchial mucosa and sub 
mucosa and by anatomical modifications of the bronchial wall. The cellular 
infiltrate is characterized by the presence of eosinophil, lymphocytes, 
monocytes-macrophages and mast cells. These cells are activated and release 
bronchus constrictor and inflammatory mediators. (Forbes,2003) Eosinophil 
have toxic effects on the bronchial epithelium through the release of basic 
proteins, while lymphocytes play a central role through the release of cytokines, 
which can activate and recruit other cells. Mast cells have an important role in 
the stimulation  of the reaction but may also maintain it. Allergen inhalation in 
the laboratory, when a late response occurs, is responsible for an inflammatory 
reaction comprising eosinophil influx and activation and T lymphocyte 
activation.(Morres;2005) The intensity of the reaction is related to the transient 
increase in airway hyper responsiveness confirming the important role of atopy 
and allergic reactions in airway hyper responsiveness.(Lissauer,2001) However 
the same kind of inflammatory reaction can be present without atopy and anti-
inflammatory treatments, even if they reduce airway hyper responsiveness, they 
may not completely abolish it. This emphasizes the complex mechanisms 
involved in persistent airway hyper responsiveness. (Clark ; 2000). 
In 2004 thirty six children with difficult asthma were studied. Asthmatic 
airways removed by bronchial biopsy show marked inflammatory changes, 
notably epithelial cell disruption and damage, and the presence of large numbers 
of eosinophil. The epithelial damage is seen in mild cases, the epithelium, thus, 
may actively participate in the inflammatory changes in asthma, where it may 
be a source as well as a target. The researchers found that drug therapy aimed at 
preventing inflammatory changes in the epithelium, such as cytokine and 
adhesion molecule expression, may be an important step forward in halting 
disease progression in asthma. (Payne, 2004). 
 
2.3.2 Allergy 
 
 Respiratory allergic diseases appear to be increasing in most countries. In 
particular, asthma morbidity and mortality have been reported to be increasing 
despite the availability of effective asthma medications. It has been also 
observed that subjects living in urban and industrialized areas are more likely to 
have respiratory allergic symptoms than those living in rural areas.  (Vonk, 
2006).  This increase has been linked to air pollution, rather than to a 
modification of the genome of the patient.(Etzael,1991) The interplay of genetic 
and environmental factors in the development of allergic disorders remains a 
subject of investigation.(Meyers,2004) In the outdoor environment, the most 
important air pollutants are sulphur dioxide, ozone and particulate matter, in 
particular diesel exhaust emissions. These pollutants, besides acting as irritants, 
increasing airways hyper-reactivity, are thought to be causal factors which act to 
modulate the immune response, with an adjuvant activity on immunoglobulin E 
(IgE) synthesis (Blumenthal,2005). In other words, a topic state can be regulated 
by environmental influences, and some subjects develop a topic disease in 
response to these environmental factors. 
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 Since airborne allergens and air pollutants are often both increased in the same 
areas, potentiation, either in the degree of acquired sensitization or in the degree 
of the response to allergens, should be considered as an important factor which 
might help to explain the increasing frequency of allergic respiratory disease. 
(Vonk, 2006). In the light of our present knowledge, it is evident that further 
investigation in human subjects, aimed at evaluating specific agents, and their 
concentration in the atmosphere, which can influence pulmonary function, is 
needed. These studies may help to explain increasing problem of asthma 
morbidity and mortality.(Kaliner,1999)  ''Allergens can trigger episodes of 
asthma in atopic patients but asthma is more often aggravated by non –specific 
factors such as cold air, tobacco smoke, dust, and fumes also respiratory viral 
infection and emotional stress.''(Haslett, 1999) 
 
2.3.3. Infection 
 
Viral infections are known to the commonest factors for asthma attacks in 
children.  And have been estimated to account for more than 80% of acute 
exacerbations of asthma in children (Gelfand, 2000) .The mechanism of 
interaction between viral infections and asthma attacks is not known in spite of 
the fact that some viruses can induce immunological changes in the host. Viral 
respiratory infections in humans have been associated with exacerbations of late 
allergic responses and asthma, as well as with airway abnormalities that persist 
after resolution of the acute infection (Murry, 2000). 
A viral respiratory infection in children increases the risk of developing asthma. 
A study in2004, show a link between respiratory syncytial virus (RSV), 
infection and asthma in mice. A related study, also in mice, suggests that a 
medication neutralizing the virus could decrease children's chances of 
developing asthma. (Mercola,2004) They hypothesized that augmented 
parasympathetic contractile mechanisms may contribute to post viral airway 
dysfunction. They studied airway physiology in anesthetized rats at one to eight 
weeks after inoculation with Para influenza 1 virus . The inoculate rat groups 
had airway obstruction (abnormal lung mechanics, gas exchange and residual 
volume), and increased sensitivity to intravenous methacholine at one to four 
weeks. Although methacholine hypersensitivity was minimal in non inoculated 
rats; these abnormalities were absent at seven to eight weeks after inoculation. 
The researchers concluded that respiratory virus infection in rats produces 
airway dysfunction that remains for weeks after resolution of the acute 
infection.( Murray,2004)On the other hand, microbes appear to be involved in 
the etiology of some cases of asthma. In addition to previous findings indicating 
that viral infection may exacerbate acute asthma, emerging evidence now 
implicates bacterial infection as a cause of chronic asthma. (Zucker, 2001)  
Richard Martin, and colleagues report detecting infection with Mycoplasma 
pneumonia or Chlamydia pneumonia in 31 of 55 asthma patients using a 
combination of polymerase chain reaction (PCR), serology, and 
culture.(Martin,2001) 
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 2.3.4. Smoking and other environmental pollution 
A child with asthma has sensitive airways inside their lungs. Certain triggers 
can make these airways narrow. If the child has asthma, smoking can lead to 
more asthma symptoms and more frequent asthma attacks. Secondhand smoke 
is a well-known asthma trigger. If the child has asthma. Secondhand smoke can 
damage the lungs by leading to long-term breathing problems or worsening 
existing breathing problems. (Joseph, 2004)The World Health Organisation 
(WHO) convened an International Consultation on Environmental Tobacco 
Smoke (ETS) and Child Health in 1999.    The Consultation brought together 
experts from developed and developing countries to examine the health effects 
of ETS on child health and to recommend interventions to reduce these harmful 
effects and eliminate children’s exposure.  (WHO, 1999)  ―Both asthma and 
respiratory systems (wheeze, cough) are increased among children whose 
parents smoke, on the basis of over 60 studies of school-aged children. The 
relative risks for either parent smoking range from 1.2 to 1.4.‖ (WHO, 1999)  
When a person inhales tobacco smoke, irritating substances settle in the moist 
lining of the airways. These substances can cause an attack in a person who has 
asthma. (Winzd, 2006)  
 Tobacco smoke irritates and damages the lungs, prompting the body to send 
more white blood cells to protect them. The more white blood cells there are, 
the more neutrophil elastase is made, causing even more lung damage. Also, the 
smoke itself changes alpha-1 antitrypsin so that it cannot do as good a job 
protecting the lungs from harm. Smokers with alpha-1 antitrypsin deficiency 
have a faster rate of lung damage (Medicine, 2006) 
The harmful effects of passive smoking (PSE) start early in intrauterine life and 
comprise direct toxic effects of components of tobaccos smoke on the fetus as 
well as indirect effects by impeding the normal nutrition of the growing child 
over effects on the placenta. Consequences are diminished birth weight, and 
increased natal mortality. (Wearer, 2006) The sudden infant death syndrome is 
associated with PSE as are increased incidence of respiratory illnesses in early 
childhood. Increased bronchial responsiveness, increased asthma prevalence, 
delayed lung growth and increased incidence of chronic respiratory symptoms 
later in childhood may well put these children at increased risk for developing 
chronic obstructive pulmonary disease in their later life. However; even if it is 
difficult to obtain correct epidemiological evidence, there is a body of evidence 
which suggests that the frequency of allergic respiratory diseases is increasing. 
(Murry, 2000)   
The majority of atopic patients, in particular in childhood and adolescence, 
develop immunoglobulin E (IgE) antibodies with clinical symptoms to 
aeroallergens, such as those derived from house dust mites, pollens and pets. 
Since, in the economically-developed countries individuals spend most of their 
time indoors (home, school and workplace), indoor pollutants (tobacco smoke 
etc.) and allergens (house dust mite, cats, etc.) are the most important source of 
exposure. (Marittas, etal, 2002)    
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 Researchers find  exposure of nonsmokers to environmental tobacco smoke 
(ETS) has become an important public health issue; it is generally agreed that 
increased exposure is related to morbidity and mortality. Precise prevalence 
estimates of exposure are not yet available, and measurement methodology for 
ETS exposure rates is still in its formative stage. (AAAAI, 2006) Recent 
interventions have attempted to reduce ETS exposure, particularly in children of 
smoking parents. Studies have relied primarily upon reduction of parents' 
smoking rates to indirectly reduce children's ETS exposure. In order to 
effectively design interventions to achieve reductions in ETS exposure, more 
attention must be given to smoking behaviors which lead to passive exposure. 
(Wolf, 2004); Researchers say that early exposure to smoke can speed the 
decline in lung function normally associated with age, increasing the risk of 
heart and lung problems or even death.(Winzd,2006).  ''Children breathing 
secondhand smoke are more likely to suffer from bronchitis and pneumonia, ear 
infections, coughing and wheezing, and more frequent and severe asthma 
attacks. '' (AAAAI, 2006) 
 A study of ninety-one families with at least one smoking parent and an 
asthmatic child were recruited from four allergy clinics, and interviewed 
regarding their smoking history, current residential smoking patterns, and the 
children's exposure patterns. Descriptive data are presented showing that the 
asthmatic child symptoms were mostly triggered by passive smoking. It is 
recommended that interventions focus closely on these patterns rather than on 
reduction of smoking rates alone, in order to effect reduction in ETS exposure 
especially on children with asthma. (Wolf, 2004) On the other hand; the 
Institute of Medicine committee found that the exposure to certain 
environmental pollutants such as house dust mites cause the development of 
asthma in the susceptible children. The committee also determined tobacco 
smoke as a risk factor that triggers asthma and is directly associated with the 
development of asthma in younger children (Stern, 1994). Lichtenstein added 
that asthmatic children can be particularly sensitive to outdoor air pollution 
especially what is known of ambient air pollutants such as ozone and sulfur 
dioxide. (Lichtenstein, 1997). Other researchers emphasized that air pollution 
might act synergistically with other environmental pollutants to worsen asthma 
(Nazario, 2006) On the other hand Stern  added that asthmatic children can be 
particularly sensitive to outdoor air pollution especially what is known as 
ambient air pollutants such as ozone and sulfur dioxide. Stern etal (1994); 
emphasized that air pollution might act synergistically with other environmental 
pollutants to worsen asthma. Examples are the diesel exhaust particulates that 
increase the capacity of producing IgE antibodies.(Forbes and Jackson,2003).  
2.3.5 Exercise 
 
Exercise induced asthma (or EIA) causes symptoms of coughing, wheezing, 
chest tightness to breathing, or shortness of breath. Children with EIA may 
experience breathing difficulty 5-20 minutes after exertion begins. EIA may 
occur more easily on cold, dry days than on warm, humid days. (AAAAI, 2006) 
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Exercise is considered one of the physical stimuli that can provoke attacks of 
asthma in the asthmatic child. Because children are naturally and physically 
more active  than adults; the incidence of exercise induced asthma (EIA) 
increases especially if the exercise is hard  and persists for a long period which 
considered enough for the asthmatic child to develop  bronchospasm. In other 
words; given sufficient exercise intensity, exercise can trigger acute 
exacerbations in virtually all individuals with asthma. Heat loss, water loss, 
postexertional airway rewarming, and the role of several mediators have been 
proposed as possible mechanisms responsible for the airway obstruction 
induced by exercise.(Morres,etal,2005) Exercise-induced asthma can be easily 
diagnosed and treated in the majority of patients. Physical training should be 
part of the asthmatic patient's overall plan of management. When properly 
treated, asthmatic individuals should be able to participate or compete in the 
majority of sports. (Joseph, 2005) 
When asthma is triggered only by physical activity, it is called exercise-induced 
asthma (EIA). Just as with other asthma triggers, a person who is triggered into 
an asthma attack by exercise has airways that narrow and tighten after they 
begin to exercise. In addition, the symptoms of EIA can be much worse with 
seasonal allergies. (Joseph, 2005) 
 
 
2.3.6. Emotional factors 
 
In the past it was thought that asthma was mainly an emotional disorder. Today 
The Asthma Center specialists know that the basis of bronchial asthma is a 
biochemical abnormality in the cells lining the bronchial tubes as well as hyper-
irritability of the airways. However, a subgroup of individuals who are under or 
have undergone stressful situations may find themselves suddenly wheezing. 
Therefore it is apparent that while emotional stress can be a significant 
triggering factor in asthma (Kolbe, etal, 2002). 
Researchers at National Jewish Medical and Research Center have now added 
another risk factor for the development of asthma -- the early psychological 
environment of the child. They agreed that emotional and psychological factors 
can act on the abnormally labile bronchi via the autonomic nervous system of 
the asthmatic child in a way that make the airway obstruction worse (UniSci 
Daily Java News, 2001)Emotional anxiety and nervous stress reactions from 
stress and anxiety are considered to be more of an effect than a cause. They can 
cause fatigue, which may affect the immune system, increase either asthma 
symptoms or bring on an attack. '' (Allergy and Asthma, 2001) 
2.3. 7 Gastro – esophageal reflux 
Gastro esophageal reflux is a backward flow or reflux of stomach contents into 
the esophagus. Everybody has some reflux. Abnormal amounts of gastro 
esophageal reflux can cause gastro esophageal reflux disease (GERD).  
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 This occurs when the valve of smooth muscle between the esophagus and the 
stomach does not function properly. This muscle band is called the lower 
esophageal sphincter. (National Jewish, 2006) ―It has been recognized that 
gastro – esophageal reflux can produce an increase in bronchial reactivity, 
which may be responsible for the very severe attacks of nocturnal asthma which 
occur in some children.‖(Clark andCodfrey 2000) 
In the same field several studies have shown the relationship between gastro-
esophageal reflux, bronchial asthma and chronic nocturnal cough and this 
should not be neglected, particularly in patients who present an unfavorable 
development in spite of conventional treatment. For diagnosis of gastro 
esophageal reflux, amongst other investigations, esophageal gammagraphy of 
swallowing, that detects alterations in the mobility of the esophagus, secondary 
to a possible oesophagitis. (Clark and Codfrey 2000)  The relationship between 
GER and asthma symptoms also led investigators to assume that anti reflux 
therapy would improve asthma. The results of studies on the effects of anti 
reflux therapy on asthma patients with GER are also conflicting. Some 
investigators, reported that anti reflux therapy was beneficial, whereas others 
were unable to identify its effect on asthma (Stephen, 2002) 
2.4   Genetic background   
 
The role of genetics in pediatric asthma has been studied worldwide. 
Researchers studied mostly the hyper reactivity of the bronchial airways and  
asked if this is acquired or is with the baby from birth (David, 2001).Another  
study in 2001 noticed that there was a relatively high incidence of atopy and 
bronchial hyper reactivity amongst healthy relatives of asthmatic children and 
wheezy infants. (Stockly, 2001). 
In the same field; Daily Policy Digest Environmental Issues  interviewed the 
parents of about 4000 identical and fraternal twins of four years old. They 
noticed that asthma rates were more similar among identical twins than others 
because in addition to their same home environment; they also share the same 
genes ( Koeppen ,etal 2001). In  general , genes account for 68% of the 
prevalence of asthma. They documented that even asthma is highly heritable , it 
is more likely to develop through an interaction via hereditary and environment 
( Koeppen ,etal 2001).  
 
  On the other hand; Genetic and Molecular Regulation of ADAM33: ADAM33 
was the first asthma susceptibility gene identified as a result of a genome-wide 
positional cloning effort .Astudy conducted by researchers in Southampton 
University has identified a relationship between a gene located on chromosome 
20 and asthma. This gene is ADAM33 which is responsible on the over respond 
and the process of airway passage constriction. (Maniatis, etal.2005). 
 
     On the other hand; alpha one Antitrypsine deficiency is an autosomal 
recessive disorder which results in pulmonary emphysema from the damage of 
the lower lobes of the lungs as well as liver disease. (Frederick J. 2002). 
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 Alpha one Antitrypsine is a protein circulating normally in the blood and it in 
vitro assays inhibits trypsin activity. In families in which a patient with 
pulmonary emphysema has been shown to be homozygous for deficient 
Antitrypsin activity; there is an increased incidence of pulmonary disease in 
relatives heterozygous for the deficiency. Frederick (2002) suspected that the 
alpha one anti trypsin protein is a serine protease inhibitor which inhibits 
bacterial proteinase in a mechanism that will otherwise destroy the alveolar 
architecture. However; the AAT gene consists of seven exons spanning of 12 
kilo bases and are located on the long arm of chromosome 14  PiM is the normal 
designation of the gene (Frederick, 2002).  PiM is the normal designation of the 
gene. Information from genetic epidemiological surveys shows that there were 
at least 75 deficiency alleles which have been already described. Alleles such as 
PiZ and PiS are studied by gene – mapping techniques and information showed 
that combination of alleles of major genotyping classes of interest are: ( PiMM; 
PiMS; PiMZ; PiSS; PiSZ; PiZZ). (Ehrenstein,2003). A study conducted by 
Frederick J. (2003); showed that in a total population of 4.4 billion from 58 
countries recruited from different 11 geographical regions,   there are  at least  
116 million carriers of Pi MS and PiMZ and 3.4 million deficiency allele 
combinations of ( PiSS; PiSZ; PiZZ). 
  Asthma associated with alpha 1-antitrypsin deficiency can impose serious      
impairment. A study conducted by Stoller etal (1994) in order to gather 
information about the impact of severe alpha 1-antitrypsin deficiency. Authors 
sent a survey to 1730 subscribers to a national newsletter, 850 of who had 
previously stated they had alpha 1-antitrypsin deficiency. A total of 414 
questionnaires were returned; 398 respondents said they had alpha 1-antitrypsin 
deficiency, and 300 said they had the PiZZ phenotype. Sixty-six respondents 
who said they had the disease did not know their phenotype. Among the 304 
respondents with severe deficiency, the mean age at the time symptoms first 
appeared was 35.0 years, but the mean age when the disease was diagnosed was 
41.3 years. Overall, 75.3% of respondents with severe deficiency reported at 
least one adverse effect: 44.4% retired early, and 19.1% changed to a physically 
easier job. The duration of diagnostic delay correlated with the degree of 
adverse psychosocial effects. This study concluded that Alpha 1-antitrypsin 
deficiency frequently escapes diagnosis despite many medical encounters; the 
affected individuals are often unaware of basic details of their disease, and 
many patients report adverse psychosocial effects. However; delay in 
diagnosing this disease is associated with adverse psychosocial effects.(Stoller 
etal; 1994). 
 
2.4.1 Alpha-1 Antitrypsin 
 
Alpha-1 Antitrypsin is a protein that is made in the liver. The liver releases this 
protein into the bloodstream. Alpha-1 antitrypsin protects the lungs so they can 
work normally. Without enough alpha-1 antitrypsin, the lungs can be damaged, 
and this damage may make breathing difficult. In addition, liver damage 
(hepatitis, cirrhosis) can occur in both children and adults. Alpha-1 antitrypsin 
deficiency is an inherited (passed down from parents) disorder that causes low 
levels of, or no alpha-1 antitrypsin in the blood. (Anonymous, 1994) 
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2.4.2 Alpha 1 Antitrypsin Deficiency 
 
When the lungs do not have enough alpha-1 antitrypsin, neutrophil elastase is 
free to destroy lung tissue. As a result, the lungs lose some of their ability to 
expand and contract (elasticity)( Koeppen, etal, 2001) White blood cells 
normally found in our bodies help protect us from infection. But white blood 
cells also release an enzyme, called neutrophil elastase, that can damage the 
lungs. In normal lungs, alpha-1 antitrypsin protects the lungs from the harmful 
effects of neutrophil elastase. (Savransky, 1994) 
Alpha-1 Antitrypsin (AAT) deficiency is a genetic, chronic and progressive 
disease that causes lung and/or liver problems. AAT is a protein that circulates 
in the blood throughout the body which protects the lung tissues from toxic 
agents, including an enzyme called elastase. When this AAT protein is deficient, 
the elastase level increases, destroying the elasticity of the lung tissue and thus 
causing a condition known as genetic emphysema. . (Schluchter, etal.2000) 
Everyone receives one gene for alpha-1 antitrypsin from each parent. The M 
gene is the most common type of gene, and it is normal. The person who 
inherits an M gene from each parent has normal levels of alpha-1 antitrypsin. 
The Z gene is the most common defect that causes the disorder. If a person 
inherits one M gene and one Z gene, that person is a carrier of the disorder. 
While such a person may not have normal levels of alpha-1 antitrypsin, there 
should be enough to protect the lungs. The person who inherits the Z gene from 
each parent is called "type ZZ." This person has very low alpha-1 antitrypsin 
levels, allowing elastase to damage the lungs (Murry and Nadel, 2000). 
2.4.3 Physiology of ALPHA 1 Antitrypsin deficiency 
Alpha 1-antitrypsin is produced in the liver, and one of its functions is to protect 
the lungs from the neutrophil elastase enzyme.'' Normal blood levels of alpha-1 
antitrypsin are 1.5-3.5 gm/l. In individuals with PiSS, PiMZ and PiSZ phenotypes, 
blood levels of Alpha 1-antitrypsin are reduced to between 40 -60% of normal 
levels.''.(King , 1999). 
Alpha one Antitrypsin deficiency is a genetic disorder that is characterized by an 
insufficient amount of serum AAT which predisposes to chronic obstructive lung 
disease, chronic liver disease and in some cases skin and vasculitis disorders. 
Alpha 1-Antitrypsin (AAT) deficiency is associated with predisposition to 
developing liver cirrhosis in early childhood, and chronic degenerative lung 
disease in early adult life. The probable molecular basis for the disease 
associations is known. One of the common variants, Z and S, has the propensity 
to form polymers, a phenomenon which is concentration- and temperature-
dependent. This results in accumulation of the protein in hepatocytes, the 
predominant tissue source of AAT, and leads to cell damage. AAT deficiency 
results in loss of protection in the lung against neutrophil elastase (NE) the major 
target for AAT. NE is capable of destroying the architecture of the lung, leading 
to pulmonary lung disease especially emphysema. 
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 The disease process is exacerbated by cigarette smoke, which is capable of 
oxidizing a critical methionine residue at the active site, rendering AAT an 
inefficient inhibitor of NE. The combination of deficiency and cigarette smoking 
are critical to the development of pulmonary emphysema. Researcher  identified 
a mutation in an enhancer sequence which, in all probability, predisposes to 
disease by a novel mechanism related to diminished expression of AAT during 
inflammation.(Schuchter,etal.2000) Moreover; AAT deficiency is often 
misdiagnosed as asthma or smoking- related Chronic obstructive pulmonary 
disease, as many as about 3% of all people diagnosed with COPD have alpha one 
Antitrypsin deficiency However; AAT deficiency has been identified in all 
different populations with the fact that about 20 million people are carries of the 
defective gene worldwide with the ability to pass it to their 
offspring.(Anonymous,1994)   However;  information from the American 
Journal of Respiratory and critical care medicine shows that there is a serum 
threshold level  of AAT above which the lung tissues appears to be protected. 
This threshold lies at about 35% of the average normal level. On the other hand; 
AAT is a polymorphic protein molecules which has an about of 100 different 
alleles combined in homozygous or heterozygous states and are assigned a letter 
code (A to Z). (American Journal, 2003). The most common allele is defined as 
M, and the normal individuals have a protein phenotype (PiMM). The deficient 
genotypes include Z and S variants. The most frequent deficient alleles is the Z 
variant  and those with( PiZZ) homozygousity have AAT levels of about 15% of 
the normal and  considered at the highest risk of developing AAT associated 
lung disease. However; there are about 200,000 Swedish infant screened of AAT 
deficiency in the early 1970s. (Sharp, etal, 2003). 
On the other hand; the S variant homozygousity forms give plasma levels of the 
enzyme about 60% of the normal. Heterozygous forms include PiZS, PiMS; 
PiMZ and persons with such deficient alleles are at increased risk of developing 
AAT deficiency associated diseases. The most severe cases of AAT deficiency 
are associated with the null alleles designated as PiQQ were there is no or about 
1%of the normal level of AAT. (American Journal; 2003).longitudinal lung 
function study in heterozygous PiMZ phenotype subjects found it is a matter of 
controversy whether subjects who are heterozygous (PiMZ) for alpha 1-
antitrypsin deficiency are at risk of developing pulmonary emphysema. To 
assess the role of MZ phenotype in the development of abnormal lung function 
the authors performed a 10 year follow-up study of 28 PiMZ subjects, compared 
to 28 matched-paired normal PiMM subjects. Maximal expiratory flows and 
mechanical properties of the lungs were studied, in order to determine the 
changes of the lung function parameters characteristic of pulmonary 
emphysema. Total lung capacity and residual volume increased, whereas forced 
expiratory volume in one second, expiratory flows, diffusing capacity of the 
lungs for carbon monoxide, and static transpulmonary pressures decreased in 
the PiMZ patients. The majority of the controlled functional parameters were 
found to deteriorate significantly in PiMZ patients during the 10 year period. 
Trypsin inhibitory capacity in the PiMZ group (mean +/- SD) was 0.65 +/- 0.17 
mg.ml-1 as compared to 1.52 +/- 0.3 mg.ml-1 in the PiMM group.  
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These changes exceeded the values expected as physiological changes due to 
ageing. The findings in the present longitudinal study--especially the decrease in 
elasticity, which is the primary path physiological damage in alpha 1-antitrypsin 
deficiency--support the concept that the PiMZ phenotype is a risk factor for the 
development of pulmonary emphysema at younger age than in those without the 
deficiency. (Tarjan, etal. 1994). 
 
2.4.4  Epidemiology of Alpha one Antitrypsin deficiency 
 
Alpha 1 antitrypsin deficiency is a widely distributed genetic disease. Data 
shows that there are 100,000 patients in the United States with the ZZ 
phenotype. Where the prevalence of MS and MZ phenotype in the United States 
is calculated to be (1/50). (Molucular,2005). However; the prevalence of the 
three major variants of AAT phenotypes is registered in many surveys 
throughout the world with the highest prevalence of the PIZ variant in the 
northern and western European countries compared to North America. On the 
other hand; the frequency distribution of PIS differs significantly from that in  
PIZ as it is also more homogenous. The mean gene frequency of PiS in the 
southern Europe was the highest .peaking in Iberian peninsula (Luisetti and 
Seersholm, 2004) However; the gene frequencies of PiZ and PiS variants in 
Australia and New Zealand are closely similar to those reported in north 
America  . (Luisetti and Seersholm, 2004) In South America, however; no 
reported data on the epidemiology of AAT variants. , Serres has proved in a 
global research study evidence that there is a significant prevalence of both PiZ 
And PiS alleles in populations from the middle east,  Africa; central and 
southern Asia, highlighting the fact that AAT deficiency is prevalent over racial 
and ethnic boundaries, a thing that increases the need for further researches in 
this field  . According to areas in the fast East Asia; the gene frequency of Piz is 
more in Japan than in South Korea and zero in china. (Luisetti and Seersholm, 
2004) 
In united stat 2002; Browne conducted a research study in which 26,866,600 
death certificates reports were analyzed in the multiple cause mortality files 
compiled by the National center for health statistics. The deaths choose are 
those which were occurred during the 13 year period (1979-1991). Results show 
that among all deaths there were 1930 had alpha 1 antitrypsin deficiency listed 
as the major cause of death. Moreover; the age adjusted mortality rate with AAT 
deficiency listed increased 86% from 4.3 per 10 million in 1979 to 8 per 10 
million in 1991. (Browme, 2002)Also Browme found that alpha one antitrypsin 
deficiency was reported in 2.7% of all deaths with obstructive lung disease 
among adults, where AAT deficiency was 1.2% of all deaths listing hepatic 
disease among children less than 14 years old. On the other hand; Browne 
noticed that deaths from alpha one antitrypsin deficiency were higher among 
whites than among blacks or persons of other races. The researchers emphasized 
the fact that alpha antitrypsin deficiency is an important risk factor for 
obstructive lung disease in the United States Globally; the distribution of the 
alpha 1-antitrypsin (Pi) phenotypes and subtypes was investigated in a 
population sample of 1060 unrelated individuals from Serbia (Yugoslavia).  
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The allele frequencies estimates were: Pi*M1: 0.702; Pi*M2: 0.183; Pi*M3: 
0.088; Pi*Z: 0.013, Pi*S: 0.007; Pi*P: 0.004; Pi*F: 0.003. (Geoge.G, 1994). 
  A study was conducted by Lieberman and colleagues on a sample of 965 
patients with chronic obstructive pulmonary disease in order to investigate the 
prevalence of AAT deficiency alleles especially the PiZZ  phenotypes. Results 
of this study show that 1.9% of the study population show severe deficiency 
phenotype of PiZZ while 8% are of intermediate PiMZ phenotype. ( WHO; 
2001). On the other hand; a study conducted by the AAT deficiency detection 
center in Sant Lake City on 16,748 individuals with different lung diseases 
including asthma shows AAT deficiency in about 3.1% of the total sample, of 
these, only one individual had the PiSZ phenotype while the others are of the 
PiZZ phenotypes. (Stockley ,etal ; 2001). 
Edward E. (1997) describes the asthma features in a cohort of 1129 subjects 
with serum AAT levels < 11 micro mole/liter and with PIZZ genotyping DNA 
probe analysis. In order to determine if asthma is associated with AAT 
deficiency. Results of this study show that asthma was present in 21% of the 
cohort and that features of asthma are common in those with AAT deficiency. 
However; in a small percentage of the study population 17%, an elevated IgE is 
associated with signs and symptoms of asthma and allergy history, which in turn 
is associated with an increased rate of Forced Expiratory Volume in the first 
second (FEV1) decline but is not an independent risk factor. (Edward 
etal,1997). Also, several previous studies showed and investigated that clinical 
features of asthma are present in some persons with severe AAT deficiency. 
Information from the British Thoracic Society Survey shows that among 166 
patients with PIZ AAT deficiency alleles; 11% were diagnosed as asthma. 
(Roberts, and William, 2004). However; Silverman (1989); found that among 
52 subject of AAT deficiency; asthma was present in 25% of those with an 
FEV1<65% predicted. (Edward  etal, 1997). 
In Thailand alpha one phenotypes was determined in 423 individuals from the 
northeast area of Thailand and 429 individuals from Bangkok, using the 
isoelectric focusing polyacrylamide gel. In the rural northeast areas of Thailand 
the M; S; Z, Pi alleles were detected. When measuring the serum concentration 
of alpha one Antitrypsin using the electro immunoassay; it was noticed that the 
concentrations were slightly higher among Thailand than those from the 
European countries. (Pongpaew, 1980) 
2.5 Summary 
Alpha-1 Antitripsine deficiency is an inherited disorder that can cause lung or 
liver disease. Alpha-1 is the name of a protein. Deficiency means there is not 
enough of it. This protein protects the body from being damaged by a powerful 
enzyme called neutrophil elastase. Neutrophil elastase is released from white 
blood cells to fight infection, but it can attack normal tissues (such as the lungs) 
if not carefully controlled by alpha-1 Antitripsine. A mutation in the SERPINA1 
gene can lead to a shortage (deficiency) of alpha-1 Antitripsine protein or an 
abnormal form of the protein that cannot control neutrophil elastase. 
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 Uncontrolled, neutrophil elastase destroys tiny air sacs in the lungs and will lead 
sever asthma symptoms. 
Subsequent prevention of lung inflammation due to cigarette smoking, 
infection, and airborne irritants form the most rational approach to slow the 
progression of the lung destruction associated with alpha 1 Antitrypsin 
deficiency. Currently, less commonly, many inflammatory and/or immune-
mediated diseases have been described in association with alpha 1 Antitrypsin 
deficiency. These observations are probably related to the role that alpha 1 
Antitrypsin plays in the immune response both as a target for modulation by 
cytokines and as a modulator of the immune response 
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Chapter  3  Conceptual Framework 
3.1   At the global level 
3.1.1   Definition of asthma 
''Asthma is a disease of the respiratory system that causes breathing difficulty 
and expressed by repeated but reversible episodes of constriction and 
inflammation of the airways and lungs. Typical symptoms include wheezing, 
coughing, and shortness of breath. Technically, asthma is described as a chronic 
inflammatory disorder of the respiratory system. Asthma has both a genetic and 
environmental basis. The symptoms of asthma are caused by allergic-like 
reactions of the body's immune system to environmental and behavioral 
stimuli.''(Marshal, etal, 2002) 
3.1.2International statistics 
 
According to Global Initiative for Asthma (GINA), a world-wide asthma 
research and education program, there are over 150 million asthmatic 
individuals worldwide. Some studies have revealed a 75% increase in asthma 
cases between 1980 and 1994 globally. Children accounted for the greatest 
increase in numbers.(GINA,1995) Health statistic for US in 2002 find nine 
million under 18 have been diagnosed with asthma( health survey, 2002).While 
about 2% of children in China display symptoms of asthma, approximately 30% 
of young people in Britain have indications of this disease. In Australia, the 
incidence of asthma is very high in Caucasian children, but much lower in 
Aboriginal children. Overall death rate from asthma has increased by 40% from 
1982-1992 (Beers and Berkow, 1999) asthma incidence and mortality have 
sharply increased in the past two decades, particularly among children. The 
study cites statistics showing a doubling of asthma cases from 6.8 million in 
1980 to 14.6 million in 1996, and a further increase to 17.3 million in 1999. 
(AAAAI, 2006) 
In the meddle East the prevalence of asthma increased over recent decades 
(Khalid ,etal ,2001)increase rate  recorded in Israel, kingdom of Saudi Arabia 
,Lebanon and AL-Kuwait (AL-Frayh, etal 2001) .the prevalence also increases 
in Morocco and in Iran ,it was 3.5%-5.5% respectively (Beasley,1998) 
IN Palestine  asthma considered one of the majored respiratory  disease that 
effect the mortality and morbidity rate(MOH,1999).Studies done in Palestine 
between 2000-2003 shows high risk of asthma in camps in comparing to 
villages .(Mohammad,2006) 
3.2 Classification of asthma 
The widely accepted classification of asthma in the United States is that 
recommended by the National Heart, Lung, and Blood Institute's (NHLBI) 
These guidelines place major emphasis on diagnosis, classification of asthma 
and management (NHLBI, 1997) 
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 The guidelines divide asthma severity into four classes that range from mild 
intermittent asthma   to severe persistent asthma.  This classification is based on 
history of asthma symptoms and measurements of lung function. Specifically, 
history of asthma symptoms includes the frequency of daytime and night-time 
symptoms and the effect of the exacerbations on daily activities also FEV1 
(percentage predicted). (GINA, 2002) 
NHLBI, NAEPP, GINA, and AAAAI  Guidelines  Classification is based on 
history of asthma symptoms and lung function before therapy begins and is 
described as mild intermittent, mild persistent, moderate persistent, and severe 
persistent Classification of a patient into any of these levels can be 
accomplished by assessing the frequency of symptoms or by pulmonary 
function testing.( NHLBI,1991) 
3.3 Risk factor for childhood asthma  
Risk factors are determinants of the risk of developing childhood asthma and 
may increase or decrease the probability of an individual developing the disease 
(Vonk, J 2006).Both genetic and environmental factors can increase your child's 
chances of having asthma. Children with a family history of asthma are at 
greater risk of developing the disease. (David, 1998) 
Other environmental factors that may increase your child's chances of 
developing asthma include: Previous allergic reactions to environmental 
allergens, Exposure to tobacco smoke, living in a large urban area with 
increased exposure to environmental air pollutants, Family history of asthma, 
allergic rhinitis, Obesity (Andrew, etal, 2000) 
Recent international studies have suggested a relatively strong causal 
relationship between increased risk of childhood asthma and exposure to 
antibiotics during childhood. The increased asthma risk was seen whether 
antibiotics were used to treat respiratory or non-respiratory infections The study 
was also able to evaluate any relationships between antibiotic exposure and 
asthma for confounding by other risk factors such as bedroom allergen levels, 
pet ownership, cigarette smoke exposure, and parental history of asthma or 
allergy. The result was the child is over four times more likely to develop asthma 
symptoms than the child who has never taken antibiotics.  (Wichens, 2007) 
Costa Rica,
 
one of the most prosperous Latin American nations, has a very
 
high 
asthma prevalence. A Cross-sectional study was done to examine potential risk 
factors
 
and childhood asthma the result Sensitization to house dust mites, low 
parental
 
education, and parental history of asthma are associated with
 
asthma in 
Costa Rica.
 
(Celedon, 2001) 
A case-control study was conducted by   Dr. Frank Gilliland and colleagues 
from the University of Southern California for children who developed asthma 
by age 5 and compared these children to asthma-free children. Parents were 
asked to provide information on early life exposures through interviews. 
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  Result was: children had an increased risk of asthma if they were exposed 
within the first year of life, but not at older ages, to cockroaches, herbicides, 
pesticides, farms crops, dust or animals. Exposure to wood smoke, soot or 
exhaust anytime between birth and age 5 was also associated with a higher risk 
of asthma.(Schultz.L,2003) 
Characteristics of parental atopy as factors in childhood asthma was tested in a 
cohort study of children of 476 families from birth until ages 6-7 years. They 
found that development of asthma in a child was more closely associated with 
the paternal history of atopy asthma than the maternal atopy  asthma history. 
Asthma history in the father (past or present) was significantly associated with 
asthma occurring in the children. (Alford et al, 2004)  
3.3.1 Environmental risk factors in childhood asthma. 
Genetic factors are important in determining the risk of developing asthma, 
environmental factors are believed to be the primary determinants of the 
expression of the disease (Sears, 1997) Indoor allergens and irritants play a 
significant role in level of asthma morbidity experience by children living in 
urban centers The New York State Department of Health's Center for 
Environmental Health conducted a study ,notice  that a potentially increased 
ambient air level of ammonia from industrial facilities might be associated with 
an increased risk of childhood asthma. Also environmental residential factors 
(such as frequent truck traffic in the neighborhood, chemical odors indoors, 
parental smoking, and humidifier or vaporizer use), several socioeconomic 
factors, having a family member with asthma, and having limited access to 
medical care. The results demonstrated that indoor and outdoor environmental 
factors play important roles in increasing the risk of having asthma. 
(Gomez,m,2005) 
National Cooperative Inner-City Asthma Study actually indoor as well as 
outdoor air quality. They found that a quarter of the children had relatively high 
levels of nitrogen dioxide exposure and these had more 
symptoms and lower peak flows. And once again, those children who were not 
allergic were at particularly high risk from the respiratory pollutants. (Pamela 
R.2002) Allergens in house dust have been controversially implicated
 
in the 
development and severity of asthma in children. House
 
dust include mite, cat, 
dog ,
 
cockroach, and fungi (Platts ,2005) allergens are among the most 
important because
 
of their suspected role in the development and exacerbation
 
of asthma. Recent cohort studies that measured allergen exposure
 
in infancy and 
followed children for recurrent wheeze and asthma
 
have failed to find a strong 
association with dust mite or cat
 
allergen (Lau, 2000   ) 
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 3.3.2 Genetic risk factors in childhood asthma 
 The mechanisms underlying the inflammatory response
 
in asthma are still not 
fully understood, it has become
 
clear that both genetic predisposition and 
subsequent environmental
 
exposure to allergen are integral to the development 
of the
 
disease , studies have revealed that asthma has a
 
strong genetic component 
but does not follow monogenic patterns
 
of inheritance (Michael B.2002)  Genes 
and environment play a role in the development of asthma. When asthma runs in 
families, genetic factors play a relatively large role. When asthma does not run 
in families, the genetic influence is not as significant as the environmental 
exposures. (David.L, 1998) 
Researchers define Asthma as complex genetic disorder that is highly prevalent 
in the population when compared with other genetic pulmonary disorders, such 
as cystic fibrosis, in which the genetic characteristics are more easily 
understood. Children with asthma are more likely to have a parent, who has a 
positive history of asthma and atopy (Sears, 1997). Genetic markers within and 
around chromosome 5q31-33 have been
 
linked to total serum IgE concentration 
in the United States
 
and Holland (postma, 1995). These markers provide strong 
evidence
 
of one or more loci in 5q31-33 closely involved in serum
 
IgE levels 
and bronchial hyperresponsiveness. The gene encoding
 
IL-4 is within this region 
and is a possible candidate for the
 
reported genetic linkage. (Michael, 2002) 
In this study we point to the risk of genetic factor by alpha 1 Antitrypsin 
deficiency. Seersholm N.  Conducted a research cohort study on 1551 PIMZ 
patients in Denmark in order to study the risk of the deficiency alleles of alpha 
one Antitrypsin and increasing the incidence and the prevalence of obstructive 
pulmonary diseases. (Seersholm, etal.2000) Results showed that 47 patients 
identified with a discharge diagnosis of obstructive pulmonary disease in 
comparison with 206 patients with the same diagnosis in the control group 
giving a relative risk RR = of 2.2. However; 36% of the cohort were first degree 
relatives of the Piz index cases which give a notice that this group was at 
increased risk of hospitalization admission of obstructive pulmonary disease   
with a relative risk of 3.4.  The researchers concluded that the PIMZ  phenotype 
considered a risk for hospital admission for  obstructive pulmonary disease  
only if they are first degree relatives of (PIZ) index cases. (Seersholm, 
etal.2000) 
3.3.2.1 Genetic transmission of AAT deficiency 
AAT Deficiency is hereditary, transmission occurs when defective genes are 
inherited from both parents. Our conceptual frame work depend on table( 3.1 
,3.2 ,3.3 ) A person who inherits a normal gene, called genotype (MM), from 
one parent and an AAT deficient gene, genotype (ZZ) from the other parent 
becomes a carrier of the AAT-deficient gene, i.e. genotype (MZ). Few if any 
symptoms will appear in a person said to be a carrier of the gene. (Canada Lung 
Association,.2005)and the following table  clarify : 
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Table 3.1  
  
However, if both parents are genotype (MZ) or carriers, they can pass down 
normal, carrier or AAT-deficient genes to their children.  
Table 3.2  
 
If one parent is a carrier, genotype (MZ), and the other is normal, genotype 
(MM), they have a 50/50 chance of having a carrier child.  
 
Table3.3  
Source :( Canada Lung Association, .2005) 
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 3.4 At the regional level 
To compare the trends of asthma mortality
 
and place of death in young patients 
between the years 1980 and
 
1997 retrospective study for different major 
population groups in Israel was done the result was  absence of a difference in the 
mortality rates
 
outside of hospitals between Jews and Arabs suggests similar
 
quality and accessibility of health care and no genetic predisposition
 
for death 
from asthma.( Picard E, 2002).Anther study was done in Ben-Gurion University 
of the Negev, Beer-Sheva, Israel The aim of this study was to examine a possible 
association between birth season (date of birth) and future development of asthma 
in children. They conclude that Asthmatic children were more likely to be born 
between March and June and least likely to be born between October and 
December, compared to controls (P < 0.05).Farther study was done at al-Iraq 
about risk factors for asthma among primary school children in Baghdad the 
result were : significant risk factors for asthma development: crowding rate of > 
or = 5 (odds ratio [OR]=1.65, 95% confidence interval [CI]=1.1 - 2.4), lower 
educational level of parents, prematurity (OR=1.61, 95% CI=1.003-2.59), low 
birth weight (OR=2.41, 95% CI=1.87-3.09), family history of asthma whether 
father (OR=3.86, 95% CI=2.54-5.87), or mother (OR=8.27, 95% CI=5.21-13.15) 
or sibling (OR=4.33, 95% CI=3.24-5.8) CONCLUSION: Crowding, low parental 
education, prematurity, low birth weight, family history of asthma and smoking 
are significant risk factors for asthma development among primary school 
children. Efforts must be concentrated for hygienic environment, good antenatal 
care and quitting smoking habits in order to overcome this health problem.( 
Kubaisy  W,2005) 
 
3.5 Asthma study in Palestinian  
 
Study was conducted in autumn of 2000, with a sample size (3,382) 
schoolchildren ,aged 6-12 yrs from  12 schools in   Ramallah District /Palestine, 
the researcher were  investigate the prevalence and severity of asthma and 
asthma symptoms in schoolchildren. They fined; children from refugee camps at 
higher risk of asthma than children from neighboring villages or cities. 
Prevalence of asthma and asthma symptoms in Palestine appears like of Jordan, 
and lower than Israel, Kuwait and Saudi Arabia, and more than developed 
countries. (El-Sharif N, etal,2002) 
Nested case-control study was done in Ramallah in 2001; the researcher looked 
for domestic mite and pet allergens and endotoxin in Palestine. Results were 
higher level of Endotoxin compared to developed countries. Also the researcher 
fined that   indoor environmental factors such as dampness seemed to be 
important determinants for allergen and endotoxin, but living habits such as lack 
of mattress cover appeared unimportant. (El Sharif N, etal, 2006)  
Geographical variations of asthma and asthma symptoms among schoolchildren 
aged 5 to 8 years and 12 to 15 years was study in two districts (Ramallah and 
North Gaza in Palestine, the results  shows that  Younger children living in 
North Gaza district have  slightly higher prevalence rates for asthma and asthma 
symptoms . 
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Older children had higher rates in Ramallah district the prevalence  of  asthma 
symptoms in Palestinian children are similar to several countries in the 
Mediterranean region such as Spain and Turkey, but lower than other Middle 
East countries such as Saudi Arabia and Israel. Reasons for such differences 
were related  to different environmental and lifestyle factors. (El Sharif N, etal, 
2003) A study publish in 2003 looked for Familial and environmental 
determinants for wheezing and asthma in a case-control study of school children 
in Ramallah- Palestine. Showed  that familial diseases are significant predictors 
of childhood asthma in Palestinian children. Moreover, indoor environment 
such as presence of cats and domestic moulds also appear to play a role. (El 
Sharif N, etal, 2003) 
 
3.6 Intervention studies 
 
According to the experience of many practitioners, the lack of adherence to 
prescribed treatment for pediatric asthma  is the single most important 
explanation for occurrences of uncontrolled asthma that necessitate care in the 
hospitalization (Goodkin, 2000). A research study emphasize  that Barriers to 
effective asthma care that currently exist include the persistence of 
environmental risk factors, disparities in care that stem from poverty and 
cultural differences ,also  parental adherence to asthma treatment plans was 
affected by their own health beliefs about medication usage and safety.( 
Martha K,2005) 
A new experimental procedure involves injecting "anti-IgE" substances that 
combine with IgE in the blood. This prevents IgE from stimulating the release 
of histamine from mast cells. It is hoped that anti-IgE treatments would reduce 
the amount of corticosteroid use by asthmatic patients. So far, this form of 
treatment provides only temporary relief and scientists are actively searching for 
more effective anti-IgE medications.(AAAAI,2006)  children could then be 
placed in early intervention programs that would be designed to help them avoid 
specific situations that could set off their immune systems and produce typical 
asthma symptoms. (Hall, I 1997) 
Future research may lead to the development of genetic screening tests that can 
identify children who may be at risk for developing asthma. A number of major 
gene therapy research projects are now focusing on developing new techniques 
for controlling the activity of genes involved in producing symptoms of asthma. 
Researchers want to figure out how to shut off or reduce the intensity of typical 
symptoms of asthma without impairing normal body function. (Hall, I 1997) 
Approximately 1% of people in North America carry the PiZ defect in the gene 
encoding the serum protein alpha 1-antitrypsin (AAT). Homozygote is subject 
to early onset emphysema and liver disease. (Savransky, 1994); conducted a 
study through which he demonstrated a means of correcting this gene defect and 
a point mutation in chromosome 14. Results of this study show that when 
exercised on human PiZZ GM2522 fibroblasts, targeting replaces exon V of the 
endogenous gene, containing the PiZ mutation, with the exon V counterpart of a 
normal complementary DNA. 
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  Simultaneously displacing the mutated exon V away from its promoter.  This 
study concluded that targeted homologous recombination offers advantages in 
potential gene therapy to correct AAT defects. (Savransky , 1994).  
King, and other researchers examined the roteinase-antiproteinase balance in the 
bronchoalveolar lavage (BAL) fluid from alpha-1-proteinase inhibitor (alpha 
1PI)-deficient lung transplant recipients to determine whether they would derive 
benefit from intravenous augmentation therapy with alpha 1PI. BAL fluid from 
eleven alpha 1PI-deficient lung transplant recipients and eight control subjects 
was assayed for free neutrophil elastase activity, immunoreactive alpha 1PI, and 
elastase inhibitory capacity. However, three of seven alpha 1PI-deficient lung 
transplant recipients had measurable free elastase activity, which was inhibited 
ex vivo by addition of alpha 1PI. The researchers concluded that alpha 1PI-
deficient lung transplant recipients demonstrate free elastase activity in BAL 
fluid during severe lower respiratory tract inflammation, which is not present 
during health. Intravenous supplementation of alpha 1PI-deficient lung 
transplant recipients with exogenous alpha 1PI during respiratory tract 
inflammation may be indicated to inhibit elastase-mediated injury to the 
transplanted lung. (Schluchter, etal, 2000) 
Also; related to the augmentation therapy; Weccker M. found in his study; that 
in patients with severe alpha-1-protease inhibitor (alpha 1-Pi) deficiency forced 
expiratory volume in first second (FEV1) is an accepted parameter to monitor 
the progression of emphysema. In a patient with severe alpha 1-Pi deficiency 
(PiZZ) more than 1,000 FEV1 measurements were performed over a period of 
12 years. FEV1 dramatically decreased initially (delta FEV1 > 500 ml/year), but 
stabilized after augmentation therapy was instituted. Three years later, the FEV1 
decreased again abruptly; the deterioration was paralleled by an increasing 
number of severe bronco pulmonary infections. This nonlinear decline implies a 
positive influence of augmentation therapy and a deleterious effect of 
bronchopulmonary infections in the disease (p < 0.0005). Daily variation of 
FEV1 in infection-free intervals exceeded 30% and was thus higher than the 
mean decrease in FEV1 per year (Weccker, etal, 2001) 
Assessments of alpha 1-antitrypsin replacement therapy (AAT) for effected 
Patient characteristics were analyzed along with the possible side effects of the 
treatment and its efficacy in maintaining appropriate AAT blood levels the 
treatment protocol began with 4 weekly intravenous doses of 60 mg/kg AAT 
(Prolastin) and continued with monthly doses of 240 mg/kg. AAT serum levels 
were measured before each dose. Every 6 months pulmonary function tests   
were performed. No side effects of treatment was  observed. (Misaritlles, 1994) 
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Chapter 4 Methodology 
 
4.1 Introduction 
This chapter describes the methodology used in the present study. The design, 
setting sample, instrumentation, data collection and data analysis procedures are 
discussed. 
 
4.2 Study design 
This study is case control study. Cases were defined as children, aged (5-16) 
diagnosed with Asthma (cases) and controls were defined as children within the 
same age group who were diagnosed with other diseases 
 
4.3 Target population  
The target populations for this study were Palestinian children whom live in 
east Jerusalem and their age rang between (5- 16 years) old. 
 
4.4 Sampling 
According to the study aim and objectives a case- control study and non -
random purposive sample were used to collect data from all asthmatic child  (5-
16) years old ,whom attending the chosen  five health center (Ministry of health 
centers, Arab health center ,Spafford clinic ,Makassed Islamic charitable 
society, , and klalit pediatrician clinic) also we include tow major hospital in 
east Jerusalem(Augusta Victoria  Hospital ,AL- Makassed Hospital). The 
sample size was 300 child, 100 was asthmatic case and 200 child was a control 
according to appendices (4.5)  
  
4.5 child inclusion and exclusion criteria 
4.5.1 Selection criteria for cases: 
1.        Children whom (Age group between 5-16 at study period). 
2.        Children who were diagnosis with asthma by a pediatrician. 
3.        Place of the child's residence is east Jerusalem. 
4.         Family consent for the participation of their child in the study 
 
4.5.2 The selection criteria for control 
 
1.      Children whom (Age group between 5-16 at study period). 
   2.  All children attending the clinic for treatment except children with                                            
upper and lower respiratory tract infections. 
3.      Place of the child's residence is east Jerusalem. 
   4.      Family consent for the participation of their child in the study. 
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4.6 The study setting 
The study was carried out in east Jerusalem center s ,mainly in the following 
sites  , Ministry of health centers, Arab health center ,Spafford clinic ,Makassed 
Islamic charitable society, klalit  pediatrician  clinic) two  major hospitals  in 
east Jerusalem(Augusta Victoria  Hospital ,AL- Makassed Hospital) .All of case 
and control were interviewed  in health setting  . Blood aspiration was carried 
out in above mention area . 
 
4.7 Data Collection 
The author approach all hospitals and health centers administration and 
permission and obtained (consent form) prior to data collection  and prior to  
blood aspiration as per the University policy. 
Data was collected through a questionnaire and blood tests. The questionnaire 
was filled by the researcher during the clinical interview. 
The questionnaire composed of thirty questions divided into six domains:- 
 Demographic data, History of child health (familial), current child health, 
Illness attack (Asthma), Environment risk factors, and knowledge about Asthma 
Management. 
 Blood samples, we collected 2-3cc of whole blood in EDTA tube after 
obtaining consent of agreement for each child parents   
 
4.7.1 Blood samples  
In EDTA tubes from each child or from children who met the criteria and 
his/her family agreed to participate a total of 150 blood samples (50 case ,100 
control )were collected. Which equal  50٪ of the total sample(50٪ =50case, and 
50٪=100control) total(n=150 case and control)have blood test for alpha 1 
Antitripsine deficiency. 
EDTA blood samples were collected (2-3cc) from each child and centrifuged 
for 10 minutes at 3000 rpm. Hemolysed samples were representing by new 
.sample  . 
All sample was analyzed  by expert genetic lab technician and under vision of 
the researcher  in Al-Quds university (research lab)and after permission of the  
Laboratory mangier. 
 
4.7.2 DNA Extraction 
 
4.7.2.1 DNA Purification Protocols : 
EDTA-anticoagulant blood sample was obtained by vein puncture from each 
participant child by the researcher himself and analysis at Al-Quds research 
laboratory. Then DNA was extracted from leukocytes by expert genetic lab 
technician using Master Pure 
TM
 Genomic DNA Purification Kit for Blood 
(Epicenter Technologies Co., USA) according to the following procedure: 
1-After draw 3ml of blood into an EDTA Vacutainer tube; separate fractions by 
centrifugation at 14,000 x g for 15 minutes. 
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 2- Carefully transfer 600 l of Buffy coat (the white interface between the    
plasma and the red blood 
  3-   Vortex mix the Buffy coat sample. Transfer 300 l of the sample to two 
1.5    ml micro centrifuge tubes and add 1.2 ml of Lysis Buffer. Invert 3 times to 
mix and then flick the bottom of the tube to suspend any remaining material. 
 
4-Incubate at room temperature for 5 minutes; invert 3 times to mix and then 
flick the tubes as outlined above. Continue incubating at room temperature for 
an additional 5 minutes; invert 3 times to mix and then flick the tubes 
 
5- Pellet the white blood cells by centrifugation for 25 seconds in a micro 
centrifuge. 
 
6. Pull off most of the supernatant, leaving 25 l of liquid. Vortex mix to 
suspend the pellet. 
 
7. Resuspend the white blood cells in 600l of Lysis Buffer 2 by pipetting the 
cells up and down 5- 7 times. The samples may be stored for several months at 
room temperature. 
 
8. Than add 250 l of the Precipitation Solution and vortex mix vigorously for 
at least 30 seconds. 
 
9. Pellet the debris by centrifugation for 10 minutes at ≥ 10,000 x g in a 
microcentrifuge. 
 
10. Pour the supernatant into a clean microcentrifuge tube and add 700 l of 
isopropanol. Invert the tube several (30-40) times; a stringy precipitate should 
be visible. 
 
11. Pellet the DNA by centrifugation at 4°C for 10 minutes in a microcentrifuge. 
 
12. Carefully pour off the supernatant without dislodging the pellet. Rinse twice 
with 75% ethanol, being careful to not dislodge the pellet. Centrifuge briefly if 
the pellet is dislodged. Remove all of the residual ethanol with a pipet. 
 
13. Resuspend the DNA in 100l of TE Buffer; incubate overnight at room 
temperature. Alternatively, resuspend the DNA by pipetting repeatedly followed 
by vortex mixing for 10 seconds. Store the purified DNA at -20°C. 
 
14. Quantify the DNA by using electrophoresis, spectrophotometry or 
fluorimetry. The concentration should be approximately 300 g/ml. 
 
4.7.2.2 Polymerase Chain Reaction – Restriction Fragment Length 
Polymorphism (PCR-RFLP) 
 
This method is one approach that is used for mutation detection. It consists of 
two steps: (1) specific DNA fragment amplification and (2) restriction enzyme 
digestion of the PCR product (Zuntar et al., 2003).  
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The fragments were amplified in a reaction volume of 25 µl containing 0.2 µg 
of genomic DNA, 0.2  mM dNTPs mix, 1X PCR buffer (50 mM KCl, 1.5 mM 
MgCl2, 10mM Tris-HCl), 0.625 U of SAWADY  Taq DNA  polymerase (Peq 
lab ,Erlangen), and 0.15 µg of each primer (Primers for PCR amplification 
)(Sandford etal, 1999) .The mixture was subjected to 40 cycles of 30 sec at 
94ºC, and 30 sec at 59ºC, and 10 sec at 72ºC. Initial denaturation for 5 min, final 
extension for 5 min at 72ºC. An aliquot (7µl) of the specific PCR product was 
digested with 10U TaqI(T↓CGA) (Biolabs, NEW ENGLAND), 1µl of 10X NE 
buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT pH 7.9) in a 
final volume of 10µl reaction mixture, and incubated at 65 ºC for 1 hr. Than 
subjected to heat inactivation step at 80 ºC for 20 min . inactivation step at 80 ºC 
for 20 min .For PCR amplification of the region of exon V containing the Z 
mutation the following oligonucleotide primers were 
used:5'TAAGGCTGTGCTGACCATCGTC3'and5'CAAAGGGTTTGTTGAA 
CTTGACC3'. Analysis of the S allele in exon III was performed by a similar 
method. Primers were designed so that the up stream primer introduced an 
artificial  TaqI restriction siteysis were5'GAGGGGAAACTACAGCACCTCG3' 
and 5'ACCCTCAGGTTGGGGAATCACC3'   The mutational status of the 
subjects were revealed by subsequent electrophoresis in 3% agarose gels 
containing ethidium bromide.  
 
4.7.2.3 Spectrophotometry 
A spectrophotometer is employed to measure the amount of light that a sample 
absorbs. The instrument operates by passing a beam of light through a sample 
and measuring the intensity of light reaching a detector.  
The beam of light consists of a stream of photons, represented by the purple 
balls in the simulation. When a photon encounters an analyte molecule (the 
analyte is the molecule being studied), there is a chance the analyte will absorb 
the photon. This absorption reduces the number of photons in the beam of light, 
thereby reducing the intensity of the light beam. 
The light source is set to emit 10 photons per second. Watch the motion of the 
photons and observe how some of the photons are absorbed (removed) as the 
beam of light passes through the cell containing the sample solution. The 
intensity of the light reaching the detector is less than the intensity emitted by 
the light source  
For Z- mutation ,child with the ZZ genotype show a single band of 110 base 
pair (bp),those with the MM genotype show two bands of 89 bp and 21 bp and 
those with the MZ (heterozygous) genotype show three bands of 110bp, 89bp , 
21bp as seen in (figure 4 .1  - A) 
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Figure 4.1 
A
B
 
 
For S  mutation ,individual with the SS genotype show a single band of 
98bp,those with the MM genotype show two bands of 78bp ,and 20bp ,and 
those with the MS  (heterozygous) genotype show three bands of 98bp ,78bp, 
20bp  as seen above  in (figure  4 .1 -B) 
 
 
4.8 Data Analyses: 
SPSS was used to analyze the collected data. Diagrams and tables are included 
to describe the trends and frequencies in the variables, and we will try to 
correlate some variables with each others to understand and determine the risk 
factors of Asthma in east Jerusalem district.  
 
 
4.9 Ethical consideration: 
Approval and permission for conducting the study at the hospital settings were 
obtained from the hospitals and health centers administrations after formal 
written request for that from the university (see appendixes 4.2). Full disclosure 
about the study was given to Parents who were informed about the purpose and 
objectives of the study as well as blood withdrawal procedures. In addition, they 
were informed when they except to get the result of the blood tests. 
Mother were assured of anonymity and confidentiality. Furthermore, they were 
told that they might experience some pain and re-withdrawal. 
Also, every child family was interviewed separately and was given the 
opportunity with to talk about Asthma with out critiquing the information 
provided. 
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4.10 Instrumentation: 
 The research instrument was a quantitative method which includes assessment 
of demographic variables, socio-economic status of the family and complete 
medical history. The measurement tool was piloted and initially pre-tested by 
filling it out from randomly selected mothers at some health centers. In addition 
to that, two consultants (  Dr.Ghassan Balousha   Dr. Lina El-Khairy)  were 
consulted to catch the desired validity and trust the measurement reliability, at 
this pilot, the observations of the researcher were taken into consideration and 
the questionnaire was modified consequently to ensure the clarity of the 
questions. Face to face validity of our measurement was brought to light after 
consulting expert’s consultants. Our operationalization of case was (every child 
who has dyspnea ,wheezing and difficulty of breathing and diagnosis by 
pediatrician as asthma  ) which mostly reflects the conceptual definition of our 
dependent variable. Socio-economic status of the family was constructed by 
creating a SES index which includes the educational level of the women and her 
husband, employment status, average of the family income and the place of 
residency. 
The data was then entered into the computer, coded, recoded and analyzed using 
the statistical package for the social sciences (SPSS).            
 
4.11 Pilot testing 
Pilot testing was done for 10% of total sample. Accordingly few simple 
modification were simple incorporated in the questionnaires. Two-stage pilot 
testing of ٪validity was carried out to test the clarity, consistency and relevance 
of the questions to the parents, who would be surveyed. 
 
4.12 Definition of variables: 
 
1-Gender: 
  Theoretical definition: It is divided into male and female. (PCBS, 1997) 
    Operational definition: sex of the person. 
 
2-Age:  
 Theoretical definition: Is defined as the temporal span extending from the         
birth date expressed by years (PCBS, 1997) 
Operational definition: Refers to date in which the person was born and the age 
categorized into two group from (5-10) and from (>10-16). 
 
3-Urban: 
  Theoretical definition: Any locality whose population amounts to 10,000 
person or more (PCBS, 1997) 
  Operational definition: It  refers to old city /Jerusalem. 
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4-Rural: 
Theoretical definition: Any locality whose population is less than 4,000                                                    
persons or whose population varies from 4000 to 9,999 persons but lacking four 
of the aforementioned elements (PCBS, 1997) 
 Operational definition: It referred to villages in east Jerusalem 
 
5-Camp: 
   Theoretical definition:  It refer to any locality referred to as a refugee camp 
and administered by the nations refugees and work agency in the near east 
U.N.R.W.A (PCBS, 1997) 
       Operational definition: It referred to place for sitting of Palestinian refugee 
in east Jerusalem  
 
6-Illiterate: 
 Theoretical definition: it applies to persons unable to read or write in any 
language and who were never awarded certificate from any formal education 
system (PCBS, 1997) 
   Operational definition: Any person haven’t chance or skills to write and to 
read  
                                   
 7- School education                                                                                              
    Theoretical definition: Is education level for persons who successfully       
complete the sixth elementary grade, preparatory level, and secondary level     
(PCBS, 1997) 
     Operational definition: The same as Theoretical definition 
 
  8-Graduate education  
Theoretical definition:  The highest successfully complete  educational 
attainment  ,associate diploma ,bachelor degree (BA/BS) higher diploma ,master 
degree (MA/MS),doctorate (PhD) (PCBS, 1997) 
       Operational definition: The same as Theoretical definition 
 
9- Employee 
  Theoretical definition: It refer to person engaged in certain productive activity 
or work                  
Operational definition: The same as Theoretical definition 
 
10- Labor work 
Theoretical definition: Hard careers in the course of their working lives 
(Bureau of Labor Statistics, 1986)  
Operational definition: person who works in public and private and receives 
wage 
 
11- Civil jobs 
Theoretical definition relating to citizens and their interrelations with one 
another or with the state: the civil branches of government job (Bureau of Labor 
Statistics, 1986) 
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Operational definition: person who employee in any job and have monthly 
income. 
 
12-Private work: 
Theoretical definition: It refers to individual activity or personal work (Bureau 
of Labor Statistics, 1986)  
Operational definition: any person who work and he is responsible for his work 
income.   
 
13-wheezing 
Theoretical definition: a whistling sound when breathing (Johnson, 2002)  
Operational definition: abnormal sound heard during breathing. 
 
14- Gene: 
Theoretical definition: The basic biological unit of heredity. (Frederick, 2003) 
 Operational definition  : The same as Theoretical definition 
 
15- Alpha-1 Antitrypsin deficiency:  
Theoretical definition: An inherited disorder that results in low or no 
production of a protein called alpha-1 Antitrypsin (Hegab, 2004) 
 Operational definition: The same as Theoretical definition 
 
4.13 Constrains and limitation of the study 
1-Sample size was (300 child) 1/3 of the total number have asthma and 2/3 from 
other disease therefore the sample size dose  not represent all asthma in east 
Jerusalem. 
2- Genetic marker was expensive therefore the alpha 1-antitrypsin deficiency 
test was done to 50٪ of the sample  
3-The child with asthma mostly came tired to the health center therefore few 
families refuse to share.  
4. This is a family reported study, and a recall bias might be present   so; this 
will effect the result 
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Chapter five (Results) 
 
5.1. Socio-demographic data  
 
A total of 300 children (200 controls, 100 cases) were the target group of this 
study, they were recruited from different health centers, mostly from Al- 
Makassed charitable society clinics 30.3%, among  the 300 children, 176 were 
males in a percent of 58.7%, and on the other hand, 124 children were females. 
The majority of the participants had governmental insurance in a percent of 
56.3%, while 29.3% of them had private one. Other while, 14.3% had no 
insurance.  
Figure 5.1. Show the distribution of the participants according to the recruitment 
health center. However; all the demographic data of the 300 participants are 
presented in (table 5.1) below. 
 
 
  Table 5.1.Distribution of the study population by socio demographic 
variables  
 
Sociodemographic variables Total respondents 
case control 
number % number % 
sex 
female 
male 
 
40 
60 
 
13.3 
20 
 
84 
116 
 
28 
38.7 
Age of the child 
5-10 
>10-16 
 
 
37 
63 
 
12.4 
21 
 
76 
124 
 
25.3 
41.3 
Season of child birth 
Summer 
Winter 
Autumn 
spring 
 
34 
40 
19 
7 
 
11.3 
13.3 
6.3 
2.3 
 
65 
84 
28 
23 
 
21.7 
28 
9.3 
7.7 
Place of residence 
Urban  
Ruler 
Refugee camp 
 
10 
85 
5 
 
3.3 
28.3 
1.7 
 
26 
167 
7 
 
8.7 
55.7 
2.3 
Marital status of the mother 
Married 
Divorced 
Widow 
 
80 
8 
12 
 
26.7 
2.7 
4 
 
189 
6 
5 
 
63 
2 
1.7 
Educational level of the mother 
 
Illiterate 
School education 
Graduate education 
 
 
 
10 
74 
16 
 
 
3.3 
24.7 
5.3 
 
 
4 
179 
17 
 
 
1.3 
59.7 
5.7 
40 
Educational level of the father 
 
Illiterate 
School education 
Graduate education 
 
 
 
3 
85 
12 
 
 
1 
28.3 
4 
 
 
5 
170 
25 
 
 
1.7 
56.7 
8.3 
 
 
 
Monthly family income 
 
2500 NIS and less 
>2500-5000 NIS 
5000 NIS and more 
 
 
 
0 
94 
6 
 
 
0 
31.3 
2 
 
 
1 
187 
12 
 
 
0.3 
62.3 
4 
Mothers occupation 
Without 
Employee 
 
 
90 
10 
 
30 
3.3 
 
193 
7 
 
64.3 
2.3 
Father’s occupation 
 
Labor work 
Civil jobs 
Private work 
 
Note: n=17 of the participants father 
sample were died (12 for the cases, 5 
for the controls). 
 
 
51 
17 
20 
 
 
17 
5.7 
6.7 
 
 
113 
28 
54 
 
 
37.7 
9.3 
18 
 
As shown in table 5.1, the majority of the mother's participants were 
unemployed. 5.6% of them were employees in different jobs as different clerical 
works, teacher, nurse, cleaners. 
 
5.2 Medical history of studied population 
As mentioned before the 300 studied individuals were divided into 100 
asthmatic cases and 200 controls. Asthmatic children were chosen specifically 
not suffering from the upper chest respiratory tract infections. However, as data 
show (n=31) children were newly diagnosed, while about half the cases (n=57) 
were diagnosed for a period more than three years. 
On the other hand, 74 of the cases were suffering from chest wheezing that 
diagnosed asthma, and 97 of the case children were suffering from chest 
discomfort and / or difficulties in breathing at different times. Data showed that 
97 of cases were suffering from interrupted sleep at night as a result of 
continuous cough, which are characteristics for asthma. Table 5.2   
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  Table 5.2. Characteristics of medical history variables among cases.  
 
Children medical history  
variables 
total respondents 
Number/cases Percent (%) 
 
Type of the target 
asthmatic child 
 
 
 
100 
 
 
 
100 
 
 
Duration of having asthma 
Recently diagnosed 
≤3 years 
>3 years  
 
 
31 
57 
12 
 
 
               10.3 
                19 
                 4 
Complaining of chest wheezing 
Yes 
no 
 
 
74 
26 
 
24.7 
8.6 
Children with morning chest 
discomfort/breath difficulty 
episodes 
Yes 
No 
 
 
 
97 
3 
 
 
 
32.3 
1 
Lasting of Asthmatic attack 
≤30 minutes 
30-60 minutes 
more than one hour 
Indeterminate 
Not complain 
 
44 
30 
3 
20 
3 
 
14.7 
10 
1 
6.6 
1 
 
Suffering from night coughs 
 
Yes 
No 
 
 
97 
03 
 
 
32.3 
1 
Suffering from breathing 
difficulties 
Yes 
No 
 
 
97 
03 
 
 
32.3 
1 
Time frequencies of Asthmatic 
attacks 
 
 
Night 
Day time 
Both day & night 
No suffering 
 
 
 
 
62 
14 
21 
3 
 
 
 
 
20.7 
4.6 
7 
1 
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 Frequency of Asthmatic attacks 
last month 
Twice a week 
3-5 times a week 
Almost every day 
Not at all 
 
 
 
33 
21 
43 
3 
 
 
 
11 
7 
14.3 
1 
Frequency of hospitalization with 
Asthma in the past 3 years. 
Not at all 
Once 
Twice 
Three 
Four 
Five and more  
 
40 
29 
19 
9 
1 
2 
 
 
13.3 
9.7 
6.3 
3 
0.3 
0.7 
     
5.3 asthma management& treatment 
Several questions were asked about the medical history of the children, such as 
if the children were treated for any medical conditions at the time of data 
collecting, questions about the nebulizer usage for the asthmatic child. 
All these data are presented in table. (Table 5.3) 
 
Table 5.3.Distribution of asthmatic medications variables  
Treatment and management plane Total case 
number Percent 
Having treatment during the time of 
the study 
Yes 
No 
 
 
94 
6 
 
 
31.3 
2 
Present prescribed medications 
Bronchial dilator 
Antibiotics 
Ferritine 
Coronary therapeutic drugs 
NSAID 
Antihistamine 
Prednisone 
Bronchodilator &anti allergic 
 
67 
21 
1 
2 
3 
1 
1 
4 
 
22.3 
7 
0.3 
0.7 
1 
0.3 
0.3 
1.4 
 
Frequency of using bronchodilators 
 
Seldom 
Every day 
More than once/day 
Five times and more\ day 
Once a month 
Not using 
 
 
24 
18 
24 
5 
0 
29 
 
 
 
8 
6 
8 
1.7 
0 
9.6 
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5.4. Hereditary disease  
 
Table5.4. Distribution of the hereditary disease variables among the study 
population 
did any of the family members 
suffer from: 
Total respondents 
number Percent 
Asthma 
Yes 
no 
 
77 
223 
 
25.7 
74.3 
Presence of asthma in family  
 
Brother 
Grandfather 
Father 
Mother 
ante 
Uncle 
Grandmother 
No diagnosed relatives 
 
 
 
23 
15 
18 
13 
2 
2 
4 
223 
 
 
 
7.7 
5 
6 
4.3 
0.7 
0.7 
1.3 
74.3 
 
Family history of hypertension 
Yes 
no 
 
96 
204 
 
32 
68 
Family history Heart problems 
Yes 
no 
 
57 
243 
 
19 
81 
Family history Diabetes 
Yes 
no 
 
86 
214 
 
28.7 
71.3 
Family history Kidney diseases 
Yes 
no 
 
12 
288 
 
4 
96 
Family history Cancer 
Yes 
no 
 
21 
279 
 
7 
93 
Family history Rheumatism 
Yes 
no 
 
52 
248 
 
17.3 
82.7 
As it is clear from the above table that there were different health problems 
among the families of the target children, but specifically 25.7% of them have 
asthma as demonstrated from the 77 family members who had asthma. From 
this 77; the majority are first class relatives. 
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 5.5. Home environmental data 
Literature gives us different environmental risk factors for asthma. Such as 
domestic animals. Here 29% of the participants had domestic animals mostly 
birds. Smoking is another risk factor and here about half of the targets had 
smokers in their houses. Data of the home environment are presented in the 
table 4.5 
 
Table 5.5 Distribution of home environmental risk factors  
Home environment risk factor: Total respondents 
Number Percent 
Presence of domestic animals in 
the house 
Yes 
no  
 
 
87 
213 
 
 
29 
71 
Type of animal 
Cats 
Dogs 
Birds 
Others 
No animals 
 
34 
7 
43 
3 
213 
 
 
11.3 
2.3 
14.3 
1 
71 
Presence of smokers in the house 
 
Yes 
No 
 
 
154 
146 
 
 
51.3 
48.7 
Season in which usually 
symptoms appear 
Winter 
Spring 
Summer 
Autumn 
All seasons 
Non specific 
No asthma  
 
 
45 
16 
1 
2 
28 
8 
200 
 
 
15 
5.3 
0.3 
0.7 
9.3 
2.7 
66.7 
 
 
5.6. Mother’s Knowledge about asthma 
During the interviews; mothers were asked about their knowledge on asthma. 
40% of the mothers said that they had certain knowledge on asthma but there 
were only 25.7% said that they had a lot of information about this subject. 
(Table5.6)  to evaluate this: mothers were asked different questions and they 
were answered by either yes or no. all the data related to this are presented in 
(table 5.7) 
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Table5.6  Evaluation of the mother’s knowledge about asthma 
knowledge evaluation 
variables 
Total respondents 
Number Percent 
Having knowledge about 
asthma 
Yes 
No 
 
120 
180 
 
 
40 
60 
Classification of knowledge 
Having a lot of information 
Having no information 
Having little information 
 
77 
180 
43 
 
25.7 
60 
14.3 
 
 
Table 5.7 Distribution knowledge variables about asthma among the mother of 
the targets 
 
knowledge variables: 
 
Total respondents 
Number Percent 
Does sport motivate asthma 
Yes 
No 
 
63 
237 
 
21 
79 
Does cold motivate asthma 
Yes 
No 
 
   61 
239 
 
  20.3 
79.7 
Does odors motivate asthma 
Yes 
No 
 
14 
286 
 
4.7 
95.3 
 
 
Does psychological problems 
motivate asthma 
Yes 
No 
 
 
35 
265 
 
 
11.7 
88.3 
Does climate changes 
motivate asthma 
Yes 
No 
 
 
72 
228 
 
 
24 
76 
Does parfan motivate asthma 
Yes 
No 
 
49 
251 
 
16.3 
83.7 
 
Does chalk  motivate asthma 
 
Yes 
No 
 
 
36 
264 
 
 
12 
88 
Does molds motivate asthma 
Yes 
 
39 
 
13 
46 
No 261 87 
Does smoke motivate asthma 
Yes 
No 
 
104 
196 
 
34.7 
65.3 
Does dust motivate asthma 
 
Yes 
No 
 
 
78 
222 
 
 
26 
74 
Does flowers motivate asthma 
 
Yes 
No 
 
 
23 
277 
 
 
7.7 
92.3 
Does animals  motivate 
asthma 
Yes 
No 
 
 
16 
284 
 
 
 
5.3 
94.7 
 
 
Does the exposure to animals 
initiate nasal discharge 
  
Yes 
No 
 
 
 
13 
287 
 
 
 
4.3 
95.7 
Does the exposure to animals 
initiate itching  
 
Yes 
No 
 
 
 
21 
279 
 
 
 
7 
93 
 
 
 
Does the exposure initiate 
chest wheezing 
Yes 
No 
 
 
13 
287 
 
 
4.3 
95.7 
Does the exposure to animals 
initiate difficulty in breathing  
 
Yes 
No 
 
 
 
 
                    11 
299 
 
 
 
3.7 
96.3 
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 5.7. Statistical relationship 
5.7.1. Domestic animals 
Literature gives us many different examples about domestic animals and its 
relationship with the prevalence and incidence of asthma. On the other hand; 
domestic animals are tested with the expression of asthmatic symptoms among 
the children suffering from the disease in meanings of cough; chest discomfort 
and difficult in breath. This study show strong statistical relations which proves 
domestic animals as a risk factors for pediatric asthma. As p value gives 
different readings less than 0.05 under the curve of Pearson chi square. 
Table 5.8.Distribution of children according to the presence of domestic animals 
in their home and with the different diagnostic criteria's for the cases. 
 
Variable Presence of domestic animal in the home 
environment 
P 
value 
yes no Pearson Chi 
square 
n % n %  
Type of target 
Case 
control 
 
39 
48 
 
13 
16 
 
61 
152 
 
20.3 
50.7 
 
7.285 
 
0.007 
Domestic animals 
make the child: 
 
Cough 
Chest wheezing 
Chest discomfort 
Breath Difficult 
More than one 
nothing 
 
 
 
6 
2 
3 
6 
22 
48 
 
 
 
2 
0.7 
1 
2 
7.3 
16 
 
 
 
15 
0 
1 
5 
40 
152 
 
 
 
5 
0 
0.3 
1.7 
13.3 
50.7 
 
 
 
 
16.190 
 
 
 
0.006 
complaining of 
chest wheezing: 
yes 
no 
 
 
34 
53 
 
 
11.3 
17.7 
 
 
40 
173 
 
 
13.3 
57.7 
 
 
13.7 
 
 
0.000 
 
Complaining of 
chest discomfort or 
breath difficult 
Yes 
no 
 
 
 
 
42 
45 
 
 
 
 
14 
15 
 
 
 
 
55 
158 
 
 
 
 
18.3 
52.7 
 
 
 
 
14.235 
 
 
 
 
0.000 
 
 
 
 
 
Awaking from 
cough at night 
Yes 
no 
 
 
38 
49 
 
 
12.7 
16.3 
 
 
59 
154 
 
 
19.7 
51.3 
 
 
7.208 
 
 
0.007 
48 
5.9. Statistical relationship of domestic animals variables among cases and 
controls 
Variable Distribution of the respondents by cases & 
controls 
P 
value 
cases controls Pearson Chi 
square 
n % n %  
Presence of 
domestic animal in 
the house 
Yes 
no 
 
 
 
39 
61 
 
 
 
13 
20.3 
 
 
 
48 
152 
 
 
 
16 
50.7 
 
 
 
7.285 
 
 
 
0.007 
Type of the 
animals  
Cats 
Dogs 
Birds 
others 
 
 
19 
3 
17 
0 
 
 
6.3 
1 
5.7 
0 
 
 
15 
4 
26 
3 
 
 
5 
1.3 
8.7 
1 
 
 
12.422 
 
 
0.014 
 
 
 
5.7.2 Presence of smoker among family members 
 
 
Table 5.10 Distribution of children according to the presence of smoker in their 
home environment with the prevalence of asthma and with the different 
diagnostic criteria's for the asthmatic children 
 
Variable Presence of smoker among family members P 
value yes no Pearson 
Chi 
square 
n % n %  
Type of target 
Case 
Control 
 
65 
89 
 
 
21.7 
29.7 
 
35 
111 
 
11.7 
37 
 
11.215 
 
0.001 
Hospitalization in the 
last three years 
 
Not at all 
Once 
Twice 
Three 
Four 
five  
 
 
 
115 
21 
9 
6 
1 
2 
 
 
 
38.3 
7 
3 
2 
0.3 
0.7 
 
 
 
125 
8 
10 
3 
0 
0 
 
 
 
41.7 
2.7 
3.3 
1.0 
0 
0 
 
 
 
10.091 
 
 
 
0.073 
 
 
 
 
 
 
 
 
 
 
49 
complaining of chest 
wheezing: 
yes 
no 
 
 
48 
106 
 
 
16 
35.3 
 
 
26 
120 
 
 
8.7 
40 
 
 
7.2 
 
 
0.007 
Using bronchial dilator 
 
Seldom 
Daily 
>once/daily 
five times/month  
not using 
 
 
32 
17 
9 
4 
92 
 
 
10.7 
5.7 
3 
1.3 
30.7 
 
 
16 
1 
15 
1 
113 
 
 
3.3 
0.3 
5 
0.3 
37.7 
 
 
24.8111 
 
 
0.000 
Duration of being 
asthmatic 
Newly 
Less /3years 
More/3 years 
No asthma 
 
 
21 
38 
5 
90 
 
 
7 
12.7 
1.7 
30 
 
 
10 
19 
7 
110 
 
 
3.3 
6.3 
2.3 
36.7 
 
 
12.365 
 
 
0.006 
Awaking with  
difficult in breath 
Yes 
No 
 
 
66 
88 
 
 
22 
29.3 
 
 
31 
115 
 
 
10.3 
38.3 
 
 
16.018 
 
0.000 
 
frequency of   chest 
discomfort (among 
Smokers family 
members) 
 
Twice 
Every night 
> twice/week 
Always 
Not at all  
 
 
 
 
 
 
19 
9 
17 
22 
87 
 
 
 
 
 
 
6.3 
3 
5.7 
7.3 
29 
 
 
 
 
 
 
14 
7 
4 
5 
116 
 
 
 
 
 
 
4.7 
2.3 
1.3 
1.7 
38.7 
 
 
 
 
 
 
23.705 
 
 
 
 
 
 
0.000 
 
As noticed from the statistical relationships in the previous table; the effect of 
having a smoker among family members has a great effect on being asthmatic 
or not. 
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 5.11 Statistical relationship of family history for asthma among cases and 
controls. 
Variable Distribution of the respondents by cases & 
controls 
P 
value 
cases controls Pearson Chi 
square 
n % n %  
Family history of 
asthma 
Yes 
no 
 
 
56 
44 
 
 
18.7 
14.7 
 
 
21 
179 
 
 
7 
59.7 
 
 
72.34 
 
 
0.000 
Relationship of 
asthmatic family 
member to the 
child 
Brother 
Grandfather 
Father 
Mother 
Untie 
Uncle 
grandmother 
 
 
 
15 
12 
15 
10 
2 
0 
2 
 
 
 
5 
4 
5 
3.3 
0.7 
0 
0.7 
 
 
 
8 
3 
3 
3 
0 
2 
2 
 
 
 
2.7 
1 
1 
1 
0 
0.7 
0.7 
 
 
 
80.65 
 
 
 
0.000 
 
 
As shown from the above table there is a strong positive relationship for asthma 
among family members and the children as being cases and controls. 
5.8 Genetic risk factor 
As shows in next figure we used the genetic testing, looks for most common 
gene changes associated with alpha -1- Antitrypsine deficiency known as S and 
Z, the DNA was gathered from blood sample. 
M is considered the normal version of the gene people with MZ or MS are 
called carriers people with two copies of Z are likely to have the most severs 
complication people with two copies of s or a combination of   S and Z are at 
slightly less risk for developing complications. 
Analysis of the alpha -1- antitrypsin Z and S mutations using restricting 
endonuclease digestion figure (5.2) Taq I digestion of PCR products amplified 
from exon V yields and 89 – bp fragment from the M allele and a 110 – bp 
fragment from Z allele.   
 
51 
Figure (5.3) TaqI  digestion of PCR products amplified from exon III yields a 
98 – bP fragment from M allele and 78 – bp fragment from S allele L = 100bp 
DNA ladder both figure ( 5.2 ,5.3 ) shows no mutation. 
 
Figure5.2 Taq I digestion of PCR products amplified from exon V yields and 89 
– bp fragment from the M allele and a 110 – bp fragment from Z allele   
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Figur 5.3 TaqI digestions of PCR products amplified from exon III yields a 98 – 
bP fragment from M allele and 78 – bp fragment from S allele 
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Chapter (6) Interpretation and Discussion. 
 
6.1 Introduction 
  The present study is one of many study that focus on asthma in Palestine, but 
the first study that concerned with environmental and genetic risk factor for 
pediatric asthma in east Jerusalem. The purpose of this study was to identify the 
most environmental genetic risk factors that effect pediatric asthma in east 
Jerusalem. To fulfill the purpose of our study, a case control design was 
conducted and 300 pediatric participant were our target population n=100 child 
selected from different health center diagnosed with asthma by pediatrician and 
n=200 was the control whom selected from other disease from the same study 
area. The distribution of participants in related to health center is clarify in 
(Figure 5.1) 
Non random purposive sample was used to collect the data from participant 
child family and the respondent group range between (5-16) years old. 
A locally designed questionnaire that included both close and open  ended 
question was used to fulfill the purpose of our study. Mainly we concentrate 
about the most environmental risk factor that induces the attack ,on the other 
hand we investigate the phenotype (Z) and (S) mutations of alpha -1- 
antitripsine genotype as genetic  risk factor or  as a marker  for pediatric Asthma 
. 
We found that second hand smoking, domestic animal and family history are 
positive association with asthma but Alpha -1- Antitripsine deficiency was 
negatively associated with asthma. 
 
6.2 Main Result  
              Demographic data was obtained from 300 participant family child. 
33.3% of total respondents were cases (n = 100) and 66.7 of total respondents 
were control 
 (n =200). The majority of respondents were males 58.7% (n = 176) on the other 
hand 41.3% of the children were female (n = 124) , this is similar to study 
published on 2002 at Allergy Journals in which the writer emphasis that boys 
are at greater risk of asthma in childhood (Vermeulen, 2002) . Explanation for 
this shift in asthma predominance from boys to girls through aging have been 
discussed in several reviews on sex differences (vonk,2006), on the other hand 
when we look for population size and structure in Palestine, we can see that the 
males constituted 50.7% and females 49.3% out of total population in Palestine 
,this may give another explanation .Other researcher concluded that asthma 
predominantly occurred in boys in child hood, with male  to female ratio of 2:1 
until puberty when the male to female ratio become 1:1 (Morris,2005). 
 
Age group was chosen from (5-16) years old, as e medicine article mention that 
Two thirds of all asthma cases are diagnosed before the patient is aged 18 years, 
Approximately half of all children diagnosed with asthma have a decrease or 
disappearance of symptoms by early adulthood(Morris, 2005). 
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Anther finding that 41.3% of total participant child was born in winter (n = 
124), 33% born in Summer 15.7% borne on Autumn and 10% of all sample 
borne on Spring department of epidemiology in Ben-Gurion University of 
Negev / Israel find an association between birth season and future development 
of childhood asthma farther more, asthmatic children were more likely to be 
born between march and June and birth season during late winter and spring 
associated with asthma during childhood (Gazala,2006) and this match our 
result for season of child birth in summer and winter equal (33%,41.3) 
respectively. 
  
On the other hand ruler of east Jerusalem occupied the large area in related to 
place of residence, approximately 84% of total sample was from villages and 
12% related to urban and 4% related to camp as seen in table (5.1) and this 
result may reflect the nature of east Jerusalem villages, mostly villages in this 
area like city, a lot of pollution, a lot of manufactory in addition to car’s 
pollution, and agricultural land very small. 
Education level of mother’s and father is important in dealing with asthma child 
,study was done about the risk factors for asthma among primary school 
children and one of main result was lower education level of parents consider 
one of significant risk factors (Kubaisy,2005) 
 
In our study the education level between asthmatic  mother and father  is not 
differ, Illiterate  3.3% for mother and 1% for father, School education 
(24.7%,28.3%)for mother and father respectively ,Graduate education (16% for 
mother and 12% for father)                                                                                     
                                                                                31.3% from cases family  and 
62.3% from control family  was the  monthly income range between 2500-5000 
NIS and  just 6%of total population exceed   5000 NIS monthly . 
 
 6.3 Health status for the study population: 
   The data shows that (n = 31) child from total (n = 100) was newly diagnosed 
with asthma – while about half of the cases were diagnosed for period more than 
three years, and in related to sings and symptom 24.3% (n = 74) complain of 
chest wheezing, 32.3% (n = 97) of case children were suffering from chest 
discomfort and 32.3% (n = 97) awaking at night as result of cough. 20% (n = 
60) of total study population reported that they admitted to hospital from once to 
five and more due to asthma. 
 
6.4 Hereditary disease 
Asthma have been recognized to have a familial basis the exact mechanisms that 
that underlie this familial basis unknown but there is strong association between 
family history and having asthma in our study specifically 25.7% of total 
population had history of asthma in first class relatives, our findings are 
consistent with other similar studies (Cloutier, 2005) . 
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7.4 Environmental risk factor  
7.4.1 Domestic animals and asthma. 
Anther findings in our study that domestic animals (cats, dogs, birds) trigger 
asthma attacks, however the dander which consists of small scales or flakes of 
dead skin cells that are continually shed by all animals and these dander is 
sticky and easily airborne and our result is consistent with other studies that 
identified the proteins in dander can trigger asthma attacks in people with 
allergic asthma (AAAI,2006). 
 
7.4.2 Secondhand smoke and childhood Asthma. 
Secondhand smoke is consider one of asthma trigger; a kids health article 
mention that smoking causes the airways to become swollen, narrow and filled 
with sticky mucus; the same problems that cause breathing trouble in child with 
asthma(joseph,2004) . 
One of the main findings of this study that the effect of having smoker among 
family members has a great effect on being asthmatic or not from all population 
have a smokers in their home (n = 154), the case(n=65) and control (n=89). 
Frequency of chest discomfort between asthma case and second hand smoking 
is strongly related 
 (p  0.000). 
Our results are consistent with other studies that identified second smoke  a 
significant risk factor for asthma and also increased respiratory symptoms, such 
as wheezing and difficulty of breathing  (Swartz,2005; AAAI,2006) also WHO  
mention ETS is real and substantial  threat to child health and causes adverse 
health effects, worsening of asthma ,also coughing  and wheezing (WHO 
,1999).  From our study results we conclude that other hereditary disease such 
as( hypertension  heart problems, diabetes, kidney disease, cancer and 
rheumatism) were reported in the child family but not significant related to child 
asthma. 
 
7.4.3 Asthma and house dust. 
Studies showed significant relation between pediatric asthma frequency to  
house dust (p = 0.001). 20.7%  from all cases gets more than on symptom if 
they exposed to house dust , our finding are similar to other study (cloutier, 
2005) that indicate asthma frequency and other risk factor such as smoke, dust, 
cockroaches are strongly related. 
Exercise is anther risk faction that we take care about but we find it not 
significantly related to asthma symptom. 
 
7.5 Genetic risk factor. 
7.5.1 Alpha -1- antitrypsin deficiency and asthma . 
The first 150 sample collected (case n = 50) and ( control n = 100) were 
checked for alpha -1- antitrypsin deficiency genotypes Z,S in Al- Quds 
university research lab, we demonstrated that our sample (n = 150) were of M 
genotype, and S,Z genotypes were detected . 
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Our finding result was no consistent association between alpha -1-  Antitripsine 
genotypes S and Z and pediatric asthma. 
Explanation for this result; that there is no one asthma gene, several genes 
interact and cause susceptibility to asthma, anther explanation our sample was 
small (n = 150) and requires farther confirmation also many study emphasize 
that genes need environmental stimuli to be expressed. (Akawi, etal, 2006) 
 
7.6 Conclusions 
Environmental genetic risk factor for pediatric asthma in east Jerusalem / 
Palestine is our case control study, sample was consist of 300 participants child 
(n = 100 asthma case) ( n = 200 control), the purposive sample was chooses 
from different health center, and hospital distributed in east Jerusalem area, the 
aim of the study was to identify the environmental genetic risk factors for 
pediatric asthma in children aged between 5 – 16 years old. 
We prepared 300 questionnaires according to the international study of asthma 
in childhood criteria 50% of total  sample was checked for genetic risk factor (n 
= 50 case, n = 100 control) and alpha -1- antitripsine genotype was preformed 
by expert genetic lab technician in Al-Quds research laboratory. 
Result was : A family history of asthma, presence of domestic animal in home, 
and second hand smoking was strongly associated with environmental risk 
factor for pediatric asthma – anther finding in our study that their was no 
association between alpha -1- Antitripsine genotypes S and Z and pediatric 
asthma in east Jerusalem. 
We can conclude that environmental risk factor such as family history of 
asthma; domestic animal and second hand smoking seemed to be important 
effect pediatric asthma attack but alpha -1- Antitrypsine  
deficiency shows no mutation. 
 
6.8 Recommendation 
 
1-Designing of health education programs about environmental risk factor of 
asthma to increase awareness of people 
 
2-Education and training program for health team in east Jerusalem centers to 
improve the outcome for management of asthmatic patient. 
  
3-Establish screening program for AAT deficiency in east Jerusalem centers. 
  
4-Repeat this study on a larger random sample on same community (east 
Jerusalem). 
 
5-We suggest comparative study using three communities such as (city, village 
and camp) or to be more generalize 
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Appendices 4.8   East Jerusalem map 
 
 
 
 
Source: The Palestinian Academic Society for the Study of International 
Affairs (PASSIA) 
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4.9The study questionnaire (English ) 
 
Child Asthma Questionnaire 
 
 
Demographic Data: 
 
 
1-Childs Name   _______________________ 
2-Gender   M ____       F_____  
3-Age 
  1-   (5-10)                               2-   >10-16 
4-Home Phone Number _______________________ 
5-Type Insurance   
              a- Government  b- Privet               c- No Insurance 
7-Name of the health center  
     -------- 1-Al- Makassed Islamic Charitable Hospital 
     --------2- Augusta Victoria  Hospital 
     --------3- Makassed Islamic Charitable center 
     --------4- Arab medical health center 
     --------5- American medical center 
     --------6-Palestinian ministry of health center 
 
8-Place of residence:  
   1-urban                  2- Ruler                          3-refugee camp 
9-laboratory code   (---------------------) 
 
Family Status: 
 
1-Educational level of the mother: 
 
a-Illiterate                         b-School education           c-Graduate education 
 
 
 
 2- Educational level of the father: 
 
     a-Illiterate                         b-School education           c-Graduate education 
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2-Mother’s occupation: 
   a-Without                                                                      b-Employee 
 
3-Father’s occupation: 
   a-Labor work                    b-Civil jobs                         c-Private work 
 
4- Basic salary  
   a-2500 NIS and less         b->2500-5000 NIS              c-5000 NIS and more 
 
  
Medical History 
 
1. Has your child had wheezing at any time in the last month? 
  
      Yes________                      No________ 
                      
2. Did your child wake up at the morning with a feeling of chest tightness? 
  
     Yes________                      No________ 
 
3. How long does your child feel chest tightness? 
 
 - Less than 30 min ______________ 
- 30 min to 1 hour _______________ 
 - More than 1 hour ______________ 
 - Unknown ____________________ 
 
4. In the last month, has your child been awakened by cough at night. 
 
     Yes________                      No________ 
  
5. Has your child had an attack of shortness of breath (difficulty to breath) at        
last month? 
 
     Yes________                      No________ 
 
  
6. Do these attacks of shortness of breath come on _____________ 
 
Night ________ Day ______            
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Past History:- 
   
1. Has your child been treated for any other medical condition at the present 
time? 
 
 Yes _____ No_____ 
 
3. Has anyone in your family been diagnosed with asthma?  
 
 Yes _____ No_____ 
 
 If yes please describe relation 
________________________________________ 
 
 
4. How long has your child been having asthma? 
  
 ______ Newly    
______ Less than 3 years 
 ______ More than 3 years 
 
5. In the past 30 days and during the night how often did your child wake up or 
had hard time breathing  
 
 _______ 2 times a week  
 _______ Every night 
 _______ more than 2 times a week 
 _______ Constantly 
 
6. In the past 3 years, how many times was the patient hospitalized for asthma? 
 
 ___ 0    ___ 1 ___ 2 ____ 3 ____ 4 ____ 5 ____> 5 
 
 
7. Which of the following heredity problems tend to run in your family? 
  
 ______ Heart 
 ______ Diabetes 
 ______ Kidney 
 ______ Cancer 
 ______ Arthritis 
 ______ Hypertension 
 ______ Others 
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Home environment: 
   
1. Do you have domestic animal at home? 
 
 Yes _____ No_____ 
 
 
2. If yes it is                _____ Cat 
   _____ Dog 
   _____ Bird 
   _____ Others 
 
3. If your child is exposed to domestic animal dose he / she 
 
 ______ Start to cough               yes / No  
 ______ Start to wheeze   yes / No  
 ______ Get difficulty in breathing             yes /No  
 ______ Get runny nose / eyes             yes / No  
  
 
4. Does any person in the house smoke   yes / No  
 
 If yes please describe relation 
 ………………………………………………. 
 
5. Which season of the year does your child usually have asthma symptoms 
 
 _______Winter 
 _______ Summer 
 _______ Spring 
 _______ Autumn 
 
 
Knowledge and management of asthma: 
 
1.  Did you have enough knowledge to manage your child during asthma? 
                                                                                            Yes / no 
 
2.  How would you classify your level of understanding regarding your child’s 
asthma or breathing problem 
 
 ______ Very knowledgeable 
 ______ Somewhat knowledgeable 
 ______ lacking knowledge on the topic 
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 3. What triggers your child asthma attacks? 
 ______ Smoke 
 ______ Animals  
 ______ Dust 
 ______ Flowers 
 ______ Mold 
 ______ Chalk dust 
 ______ Changes in weather 
 ______ Strong smells / Perfume 
 ______ Food 
 ______ Emotional upsets 
 ______ Sports 
 ______ Others 
 
 
Treatment: 
 
 1. How often do you use an inhaler or nebulizer to treat your child’s problem? 
 
 ______ Rarely 
 ______ Daily use 
 ______ More than once daily 
 ______ 5 or more times a month 
 
   2. Does your child take any other medication? If yes, lest them 
 
 ____________________________________________ 
 ____________________________________________ 
 ____________________________________________ 
 ____________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
 
  
 
4.10 study questionnaire(Arabic) 
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اسخبٍاٌ حول يزض انزبو فً أطفال فهسطٍٍ 
 
:  يعهوياث عٍ انطفم 
                                                                                                  
و   :..../..../.......انخارٌخ
 
.................................. اسُ اٌطفً
........ أٔثٝ........     اٌدٕس       روش
) 61-01(اوثش ِٓ- 2)          01-5- (1 : خاٌعّش تاٌسٕٛا
....................... تٍفْٛ.....................     ٘اذف اٌث١د
لا ٠ٛخذ ذأِ١ٓ - 3خاص               -2حىِٟٛ              -1: اٌرأِ١ٓ اٌظحٟ
 ِخ١ُ             - 3لش٠ح                 - 2ِذ٠ٕح                - 1:          انعنواٌ
 
 )خاص بانًخخبز(......................... نزقى انًخسهسم ا
 
 
: انوضع انعائهً نلأسزة
: اٌّؤً٘ اٌعٍّٟ ٌٍزٚخح- 1
دساساخ عٍ١ا            /ذعٍ١ُ خاِعٟ- 3ذعٍ١ُ ِذسسٟ              - 2أِ١ح                   - 1     
: اٌّؤً٘ اٌعٍّٟ ٌٍزٚج- 2
دساساخ عٍ١ا           /ذعٍ١ُ خاِعٟ- 3ذعٍ١ُ ِذسسٟ            - 2أِٟ                   - 1       
                                  
: عًّ الأَ- 3
لا ذعًّ - 2ذعًّ                  - 1       
: عًّ الأب- 4
أعّاي حشج                  - 3ِٛظف                           - 2عاًِ                  - 1       
: ِعذي دخً الأسشج - 5
) 0005(أوثش ِٓ - 3)      0005-0052(ِٓ - 2)        0052(ألً ِٓ - 1       
 
 09
                                    
حارٌخ صحت انطفم 
 
 ً٘ عأٝ طفٍه ِٓ طف١ش فٟ اٌظذس خلاي اٌشٙش اٌحاٌٟ؟ -1
 لا\          ٔعُ 
 
ً٘ ٠ظحٛ اٌطفً ٚعٕذٖ شعٛس تض١ك تاٌظذس أٚ طعٛتح فٟ اخز إٌفس؟     -2
 لا\                 ٔعُ  
 
 :) فٟ إٌفسقاٌشعٛس ترض١ٟ(إرا واْ اٌدٛاب ٔعُ وُ ٠سرغشق ٘زا اٌشعٛس  -3
 
 دل١مح 03الً ِٓ - 1       
  دل١مح إٌٝ ساعح03ِٓ - 2       
 أوثش ِٓ ساعح- 3       
 لا ادسٞ- 4       
 
 :فٟ اٌشٙش اٌحاٌٟ ً٘ واْ اٌطفً ٠ظحٛ خلاي اٌٍ١ً ٔر١دح سعاي ِسرّش -4
لا \       ٔعُ   
 
:                   ًٞ٘ عأٝ طفٍه ِٓ طعٛتح فٟ اخز إٌفس خلاي اٌشٙش اٌحاي- 5    
لا \                   ٔعُ  
 
 
: ً٘ وأد ٘زٖ اٌظعٛتح فٟ اٌرٕفس غاٌثا فٟ - 6     
اٌٍ١ً  - 1               
إٌٙاس - 2               
 
انخارٌخ انًزضً نهطفم 
 
لا \  ً٘ ذعاٌح اٌطفً ِٓ إٞ ِشع خلاي اٌفرشج اٌحاٌ١ح      ٔعُ - 1 
............................. ٞ اسُ اٌّشع/      إرا واْ اٌدٛاب ٔعُ اروش
 
 
لا \  ً٘ ذُ ذشخ١ض أٞ فشد ِٓ إفشاد الأسشج تّشع اٌشتٛ   ٔعُ  - 2
 
 ٞ\ٞ اٌعلالح اٌعائٍ١ح ِٓ فضٍه\إرا واْ اٌدٛاب ٔعُ طف 
 
------------------------------------------------------- 
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: ً٘ ٕ٘ان ِشاوً طح١ح ٚساث١ح فٟ اٌعائٍح - 3
اٌمٍة     ...... 
اٌسىشٞ  ...... 
اٌىٍٝ  ...... 
اٌسشطاْ  ...... 
اٌرٙاب اٌّفاطً  ...... 
اٌضغظ؟  ...... 
......................................................... ٞ\غ١ش رٌه   حذد ...... 
 
 
سكٍ انطفم \ انبٍج 
 
ً٘ عٕذوُ ح١ٛأاخ أٌ١فح فٟ إٌّزي؟ - 1
لا \            ٔعُ 
 
: إرا واْ اٌدٛاب ٔعُ فًٙ ٘ٛ - 2
لظ      ......... 
وٍة      ......... 
ط١ٛس \ عظاف١ش      ......... 
غ١ش رٌه      ......... 
 
: إرا ذعشع اٌطفً لأٞ ِٓ ٘زٖ اٌح١ٛأاخ الأٌ١فح- 3 
٠ثذأ تاٌسعاي      .......... 
٠ثذأ تاٌظف١ش فٟ اٌرٕفس      .......... 
 فٟ اٌظذس أٚ اٌرٕفس ق٠شافمٗ اٌشعٛس تاٌرض١ٟ     .......... 
٠ثذأ تاٌذِٛع ِٚخاط فٟ الأٔف       ......... 
 
 
ً٘ ٠ٛخذ ِذخٕ١ٓ ضّٓ إفشاد إٌّزي؟  -5
لا \        ٔعُ 
 ٞ\ٞ اٌعلالح اٌعائٍ١ح ِٓ فضٍه\          إرا واْ اٌدٛاب ٔعُ طف
 
------------------------------------------------------- 
 
أٞ ِٓ اٌفظٛي الأستعح ذىْٛ عادج ِحفزج ٌٕٛتح اٌشتٛ عٕذ اٌطفً - 5
اٌشراء -1                  
اٌشت١ع -2                  
اٌظ١ف -3                  
اٌخش٠ف -4                  
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خلاي اٌشٙش اٌّاضٟ ٚخلاي فرشج اٌٍ١ً وُ ِشج اسر١مع اٌطفً ٚعٕذٖ طعٛتح فٟ    - 6
اٌرٕفس 
ِشذ١ٓ فٟ الأسثٛع - 1              
وً ٌ١ٍح - 2              
أوثش ِٓ ِشذ١ٓ فٟ الأسثٛع - 3              
تاسرّشاس - 4              
 
وُ اٌّذج اٌرٟ عأٝ ف١ٙا طفٍه ِٓ ِشع اٌشتٛ - 7
خذ٠ذ - 1
 سٕٛاخ 3أوثش ِٓ - 2
 سٕٛاخ 3الً ِٓ - 3
 
خلاي اٌثلاز سٕٛاخ الأخ١شج وُ ِشج ادخً اٌطفً ٌٍّسرشفٝ تسثة ِشع اٌشتٛ - 9
 
...... 5أوثش ِٓ .....    5.....   4....     3....     2....     1.....    0          
 
يعهوياث عٍ انًزض  
 
  )اٌشتٛ(ً٘ ذدذ٠ٓ عٕذن اٌّمذسج اٌعٍّ١ح ٚاٌّعٍِٛاخ اٌىاف١ح ٌٍرعاًِ ِع ِشىٍح طفٍه -1
لا  \      ٔعُ  
 
و١ف ذظٕف١ٓ ٔفسه ِٓ ٔاح١ح اٌّعٍِٛاخ اٌعٍّ١ح عٓ ِشع اٌشتٛ ٚاٌرعاًِ ِع ِشىٍح           - 2
طفٍه 
عٕذٞ ِعٍِٛاخ وث١شج - 1              
عٕذٞ ِعٍِٛاخ لٍ١ٍح - 2              
عٕذٞ ٔمض شذ٠ذ فٟ اٌّعٍِٛاخ عٓ ِشع اٌشتٛ - 3              
  
: ِا ٘ٛ اٌّحفز ٌٕٛتح اٌشتٛ عٕذ طفٍه غاٌثا - 3
اٌذخاْ ..........
 اٌح١ٛأاخ.........
 اٌغثاس..........
 اٌّزسٚعاخ إٌّزٌ١ح ..........
 اٌعفٓ..........
 اٌطثاش١ش..........
 اٌرمٍة فٟ اٌطمس..........
 اٌشٚائح اٌمٛ٠ح ِثً اٌعطٛس..........
 )أطٕاف ِع١ٕح(الأوً ..........
 ِشاوً ٔفس١ح ٚعاطف١ح..........
 اٌش٠اضح ..........
غ١ش رٌه      ..........
 
 
 39
 
انعلاج انذي ٌعطى نهطفم 
 
ِرٝ ذسرعٍّ١ٓ اٌثخاخ اٌّشطة ِٚٛسع ِدشٜ اٌرٕفس - 1
ٔادسا - 1
وً ٠َٛ - 2
أوثش ِٓ ِشج فٟ اٌ١َٛ - 3
خّس ِشاخ أٚ أوثش فٟ اٌشٙش - 4
 
: اٌشخاء ذسّ١ح الأدٚ٠ح اٌرٟ ذعطٝ ٌٍطفً حاٌ١ا - 2
- .................... 2- ...........................    1
-........................... 3 
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